Ulcerative colitis (strict definition, require KELA)

K11_UC_STRICT

ulcerative colitis: An inflammatory bowel disease involving the mucosal surface of the large intestine and rectum. It may present with an acute or slow onset and follows an intermittent or continuous course. Signs and symptoms include abdominal pain, diarrhea, fever, weight loss, and intestinal hemorrhage.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions K11_KELAUC	8429
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — K51 Hospital discharge: ICD-9 — 556 Hospital discharge: ICD-8 — 5631\|569 Hospital discharge: excluded ICD-9 — 5564A Cause of death: ICD-10 — K51 Cause of death: ICD-9 — 556 Cause of death: ICD-8 — 5631\|569 Cause of death: excluded ICD-9 — 5564A 2 out of 7 registries used, show all original rules.	7745
4. Check minimum number of events None	7745
5. Include endpoints None	7745
6. Filter based on genotype QC (FinnGen only)	7745

Control definitions (FinnGen only)

Control exclude: K11_UC_STRICT_PSC
Control conditions: not K11_KELAUC

Extra metadata

Level in the ICD hierarchy: C
First used in FinnGen datafreeze: DF3
Parent code in ICD-10: K50-K52
Name in latin: Colitis ulcerosa

NAME	K11_UC_STRICT
CONTROL_EXCLUDE	K11_UC_STRICT_PSC
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS	!K11_KELAUC
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS	K11_KELAUC
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	K51
HD_ICD_9	556
HD_ICD_8	5631\|569
HD_ICD_10_EXCL
HD_ICD_9_EXCL	5564A
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	K51
COD_ICD_9	556
COD_ICD_8	5631\|569
COD_ICD_10_EXCL
COD_ICD_9_EXCL	5564A
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Ulcerative colitis (strict definition, require KELA) based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	7745	3923	3822
Unadjusted period prevalence (%)	1.51	1.34	1.68
Median age at first event (years)	38.75	35.48	42.09

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
6924: Matched controls
69238

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

A07EA01

ATC

prednisolone; rectal

182.0

323.0

553

J01MA02

ATC

ciprofloxacin; systemic

2.8

323.0

3198

16162

L04AX01

ATC

azathioprine; systemic

54.9

323.0

2872

883

UJF32

NOMESCO Finland

Coloscopy

20.4

323.0

5128

8511

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

253.8

323.0

517

5561A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) ileocolitis

1816.3

323.0

332

K50.9

ICD-10 Finland

Crohn disease, unspecified

23.2

323.0

646

306

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

63.3

323.0

586

101

UJF30

NOMESCO Finland

Ileoscopy through colon

17.1

323.0

2864

2739

K51.1

ICD-10 Finland

Ulcerative (chronic) ileocolitis

331.8

323.0

1274

K51

ICD-10 Finland

Ulcerative colitis

525.7

323.0

1150

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

11.2

323.0

1825

2150

D94

ICPC

Chronic enteritis/ulcerative colitis

105.2

323.0

543

A07EC01

ATC

sulfasalazine; oral, rectal

9.0

323.0

1757

2516

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

4.3

323.0

2939

10140

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

681.6

323.0

2824

A07EC02

ATC

mesalazine; oral, rectal

1682.3

323.0

6568

756

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

+∞

323.0

6924

447

K51.5

ICD-10 Finland

Left sided colitis

766.1

323.0

4331

149

K51.2

ICD-10 Finland

Ulcerative (chronic) proctitis

266.3

323.0

1855

K50.1

ICD-10 Finland

Crohn disease of large intestine

34.6

323.0

657

209

K50.8

ICD-10 Finland

Other Crohn disease

21.3

323.0

658

340

H02AB07

ATC

prednisone; oral

6.3

323.0

2120

4540

H02AB06

ATC

prednisolone; systemic

8.6

323.0

5435

20629

A07EA02

ATC

hydrocortisone; rectal

207.2

323.0

2646

206

A07EA06

ATC

budesonide; oral, local oral

64.9

323.0

2453

580

K51.8

ICD-10 Finland

Other ulcerative colitis

315.5

323.0

1783

O99.6

ICD-10 Finland

Diseases of the digestive system complicating pregnancy, childbirth and the puerperium

54.6

323.0

436

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

10.7

323.0

848

893

56310

ICD-8 Finland

Chronic enteritis and ulcerative colitis, Ulcerative colitis

184.9

323.0

401

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

320.8

323.0

4143

320

L01BB02

ATC

mercaptopurine; oral

72.0

323.0

838

132

K51.0

ICD-10 Finland

Ulcerative (chronic) pancolitis

323.1

323.0

947

M07.5*K51.9

ICD-10 Finland

Arthropathy in ulcerative colitis

312.0

321.8

325

5562A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) proctitis

1054.6

311.6

303

P01AB01

ATC

metronidazole; oral, rectal

2.7

307.2

3278

17474

ZX120

NOMESCO Finland

Intravenous

4.6

295.0

1137

2816

5568X

ICD-9 Finland

Idiopathic proctocolitis, Other ulcerative colitis

668.0

262.4

258

JFH30

NOMESCO Finland

Total colectomy, mucosal proctectomy and ileoanal anastomosis without ileostomy

233.1

262.1

269

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

90.9

250.4

279

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.6

241.6

2234

10572

A07EC03

ATC

olsalazine; oral

314.5

238.4

241

K83.0

ICD-10 Finland

Cholangitis

17.9

230.4

369

217

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

10.2

218.7

451

468

JFG00

NOMESCO Finland

Closure of loop enterostomy without resection

37.7

183.9

237

A05AA02

ATC

ursodeoxycholic acid; oral

10.4

179.0

364

366

L04AB04

ATC

adalimumab; parenteral

8.5

178.1

407

503

K50.0

ICD-10 Finland

Crohn disease of small intestine

10.0

170.7

356

375

WX002

NOMESCO Finland

Sedation and analgesia

2.6

170.2

1507

6731

4AB02

NOMESCO Finland

40.3

169.4

215

TPH04

NOMESCO Finland

Cathetrisation of vein

2.5

166.2

1618

7600

4AA12

NOMESCO Finland

36.0

163.7

213

A06AC01

ATC

ispaghula (psylla seeds); oral

2.3

153.0

1671

8273

A02BC02

ATC

pantoprazole; systemic

2.0

152.3

4286

31386

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

11.9

145.3

275

239

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

138.7

2762

17545

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.4

136.8

1435

6911

M07.5

ICD-10 Finland

Arthropathy in ulcerative colitis

217.3

124.1

128

L04AD01

ATC

ciclosporin; systemic

7.2

123.8

315

457

1370

FHL

Colonoscopy, whole colon

28.8

121.0

166

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.0

120.2

769

2762

JFH33

NOMESCO Finland

Total colectomy, mucosal proctectomy, ileoanal anastomosis and ileostomy

307.6

118.6

120

A07DA03

ATC

loperamide; oral

5.1

115.1

388

803

WX302

NOMESCO Finland

Thoracal epidural anesthesy

3.9

111.0

491

1327

JFH10

NOMESCO Finland

Total colectomy and ileostomy

53.4

109.2

131

JFH11

NOMESCO Finland

Laparoscopic colectomy

1064.8

107.7

105

5560A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) enterocolitis

118.0

107.3

116

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

3.6

106.7

526

1556

UJF92

NOMESCO Finland

Capsular endoscopy

5.8

101.6

301

535

JGB50

NOMESCO Finland

Mucosal proctectomy and ileoanal anastomosis

342.1

101.4

102

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

4.0

96.8

417

1098

3042

Kela drug reimbursment

200.8

95.6

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

3.7

94.8

448

1277

253

Kela drug reimbursment

198.7

94.6

H02AB09

ATC

hydrocortisone; systemic

5.8

94.4

279

494

Z93.2

ICD-10 Finland

Ileostomy status

27.7

92.6

128

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.5

92.4

808

3477

C05AA08

ATC

fluocortolone; rectal, topical

2.3

91.6

1009

4876

K62.8

ICD-10 Finland

Other specified diseases of anus and rectum

11.1

90.4

176

162

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

5.1

90.1

300

611

JFF10

NOMESCO Finland

Loop enterostomy

18.2

88.1

139

4AA33

NOMESCO Finland

96.3

86.1

JFH20

NOMESCO Finland

Proctocolectomy and ileostomy

116.5

85.1

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.8

84.6

382

1047

3005

Kela drug reimbursment

Tofacitinib

31.6

83.9

112

K92.1

ICD-10 Finland

Melaena

3.6

81.1

396

1157

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

10.0

76.3

157

161

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.3

74.9

789

3709

K51.4

ICD-10 Finland

Inflammatory polyps

252.8

73.5

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

5.5

72.3

225

424

3AC01

NOMESCO Finland

8.4

70.7

160

194

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

4.8

69.5

241

513

L04AB06

ATC

golimumab; parenteral

8.6

68.4

153

182

A07AA09

ATC

vancomycin; oral

8.5

67.2

151

181

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

4.6

66.7

245

553

L04AA29

ATC

tofacitinib; oral

23.7

66.7

6419

FHL

Other measure in this category

69.7

66.3

L04AC05

ATC

ustekinumab; parenteral

14.3

66.1

114

C10AC01

ATC

colestyramine; oral

4.4

64.4

243

564

H02AB04

ATC

methylprednisolone; systemic

2.0

60.6

922

5035

M09.2*K51.9

ICD-10 Finland

Juvenile arthritis in ulcerative colitis

593.2

59.8

JFG20

NOMESCO Finland

Closure of enterostomy with resection of exteriorised loop

15.9

58.3

56902

ICD-8 Finland

Other diseases of intestines and peritoneum, Proctitis haemorrhagica (ulcerosa)

74.1

58.1

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

5.4

57.8

179

336

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

5.1

57.6

189

379

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

6.4

57.2

156

250

N02BE01

ATC

paracetamol; systemic, rectal

1.6

57.1

5463

48433

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

2.2

56.8

651

3161

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.0

56.6

851

4616

K50

ICD-10 Finland

Crohn disease [regional enteritis]

15.7

56.2

WVA20

NOMESCO Finland

Medicine administration

4.2

53.6

210

506

Z2221

NOMESCO Finland

Medical doctor

1.6

53.3

1750

12077

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

52.9

2216

16223

UJK12

NOMESCO Finland

Peroral cholangioscopy

21.3

52.6

D16

ICPC

Rectal bleeding

4.3

52.0

200

473

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

4.1

50.6

204

505

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

5.3

49.9

158

305

UJK02

NOMESCO Finland

ERCP

4.4

49.4

187

436

A02BC01

ATC

omeprazole; systemic

1.6

49.1

1538

10454

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

7.7

49.0

116

152

M07.4*K50.9

ICD-10 Finland

Arthropathy in Crohn's disease [regional enteritis]

21.7

48.3

5551A

ICD-9 Finland

Regional enteritis, Large intestine

167.8

47.9

JFG73

NOMESCO Finland

Excision of ileal pelvic pouch

471.0

47.4

UJF34

NOMESCO Finland

Left colonoscopy

9.9

47.0

JF1BD

NOMESCO Finland

Very extensive small bowel CT

10.1

46.6

1490

FHL

Sigmoideoscopy (fiberscope)

18.9

46.1

5552A

ICD-9 Finland

Regional enteritis, Small intestine with large intestine

236.5

46.0

L04AA33

ATC

vedolizumab; parenteral

161.1

45.8

JF1DG

NOMESCO Finland

Small bowel very extensive MRI with with high intensity magnet

10.1

45.6

N02AX02

ATC

tramadol; systemic, rectal

1.5

44.9

2396

18321

56300

ICD-8 Finland

Chronic enteritis and ulcerative colitis, Regional enteritis

49.4

44.8

J01MA12

ATC

levofloxacin; systemic

1.7

44.2

1031

6435

L04AA01

ATC

[U] ciclosporin; systemic

4.8

44.1

151

318

ZXE00

NOMESCO Finland

One hour or less

1.5

44.0

2391

18335

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.8

43.9

824

4809

A02BC03

ATC

lansoprazole; oral

1.6

43.4

1578

11069

UJG02

NOMESCO Finland

Proctoscopy

3.8

43.2

189

504

JH1CG

NOMESCO Finland

Extensive MRI of perianal area

9.0

43.1

105

TJF80

NOMESCO Finland

Ostomy education

6.8

42.7

110

164

5586X

ICD-9 Finland

Other non-infective gastro-enteritis and colitis[KROONINEN INFLAMMATOORINEN SUOLISTOSAIRAUS, NUD]

54.8

41.4

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.3

41.2

411

1863

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.8

41.0

755

4373

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

40.5

2270

17436

R50.9

ICD-10 Finland

Fever, unspecified

1.7

40.2

859

5213

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

40.2

1245

8379

A02BC05

ATC

esomeprazole; systemic

1.4

39.9

2274

17514

K60.3

ICD-10 Finland

Anal fistula

3.8

39.6

176

476

B01AB05

ATC

enoxaparin; parenteral

1.5

39.3

1567

11192

D18

ICPC

Change in faeces/bowel movements

3.8

38.7

168

446

JN3AD

NOMESCO Finland

Abdominal CT examination

2.1

38.6

445

2156

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.9

38.1

586

3184

JHA00

NOMESCO Finland

Anal or perianal incision

4.3

38.0

147

351

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

37.5

1568

11300

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.2

37.0

416

1990

ZXE20

NOMESCO Finland

More than three and less than five hours

1.7

36.7

763

4582

Z93

ICD-10 Finland

Artificial opening status

14.6

36.2

6410

FHL

Panprococolectomy and ileostomy

359.2

36.0

JFF13

NOMESCO Finland

Terminal enterostomy

16.9

35.8

D11

ICPC

Diarrhoea

1.7

35.5

742

4464

6525

FHL

Enterostomy occlusion

124.0

34.7

K56.7

ICD-10 Finland

Ileus, unspecified

4.7

34.6

121

262

D06BX01

ATC

metronidazole; topical

1.8

34.3

595

3369

Z98.0

ICD-10 Finland

Intestinal bypass and anastomosis status

10.6

34.2

WX402

NOMESCO Finland

General anaesthesia

1.6

33.7

998

6610

JGB40

NOMESCO Finland

Excision of rectum and end ileostomy

120.6

33.7

M45

ICD-10 Finland

Ankylosing spondylitis

3.1

33.5

187

606

JF2AB

NOMESCO Finland

Colongraphy with X-ray

13.6

33.4

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.2

32.1

341

1590

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

4.6

32.1

113

247

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

5.5

31.9

180

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

31.7

989

6626

E0000UV

ATC

1.4

31.6

2306

18370

TJJ00

NOMESCO Finland

Percutaneous needle biopsy of liver

10.8

31.6

1380

FHL

Colonoscopy, left side

36.6

31.5

K61.0

ICD-10 Finland

Anal abscess

3.4

31.3

158

476

A06AC51

ATC

ispaghula, combinations; systemic

2.3

31.1

288

1259

UJF30

SPAT

8.2

30.6

0093A

ICD-9 Finland

Ill-defined intestinal infections, Diarrhoea of presumed infectious origin

4.4

30.5

113

260

56399

ICD-8 Finland

Chronic enteritis and ulcerative colitis, Other

26.4

30.5

K91.4

ICD-10 Finland

Colostomy and enterostomy malfunction

18.5

30.0

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

3.1

29.8

170

557

JFA58

NOMESCO Finland

Endoscopic dilatation of colon

14.9

29.5

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

29.4

2102

16637

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

29.3

2700

22266

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.1

29.3

359

1784

5563A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) proctosigmoiditis

+∞

29.2

K83.8

ICD-10 Finland

Other specified diseases of biliary tract

15.2

28.5

K59.1

ICD-10 Finland

Functional diarrhoea

2.2

28.5

288

1312

UJF02

NOMESCO Finland

Peroral enteroscopy

6.9

27.1

D07AC01

ATC

betamethasone; topical

1.4

26.8

1868

14672

5761C

ICD-9 Finland

Other disorders of biliary tract, Cholangitis[CHOLANGITIS SCLEROSIVA]

140.5

26.6

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

2.3

26.5

248

1091

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.3

26.5

254

1132

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.8

26.4

176

643

C05AA01

ATC

hydrocortisone; rectal, topical

2.2

26.4

286

1347

JFG40

NOMESCO Finland

Revision of enterostomy or colostomy without laparotomy

9.9

26.3

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

26.3

1145

8236

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

4.3

26.0

235

J01DB01

ATC

cefalexin; oral

1.4

25.9

5249

48286

A03CA02

ATC

clidinium and psycholeptics; oral

2.2

25.8

280

1322

ZXC86

NOMESCO Finland

Use of endoscopic device

6.8

25.7

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

2.4

25.7

234

1014

JHD00

NOMESCO Finland

Anal dilatation

5.4

25.7

146

M05BA04

ATC

alendronic acid; oral

2.1

25.5

299

1460

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

3.2

25.2

136

432

K55.9

ICD-10 Finland

Vascular disorder of intestine, unspecified

13.5

24.9

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.4

24.7

222

958

K76.9

ICD-10 Finland

Liver disease, unspecified

3.8

24.5

107

288

JF1AD

NOMESCO Finland

Small bowel CT

7.3

24.1

UJD02

NOMESCO Finland

Gastroscopy

2.2

24.0

245

1125

JAH00

NOMESCO Finland

Laparotomy

2.7

23.8

167

629

6408

FHL

Colectomy and ileostomy

240.7

23.6

SPAT1262

SPAT

Handing over of treatment supplies

1.5

23.4

919

6460

JFB00

NOMESCO Finland

Partial resection of small intestine

3.6

22.7

104

292

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.8

22.7

387

2175

XX6XT

NOMESCO Finland

Other intravascular therapy with radiological guidance

8.0

22.1

Z94.4

ICD-10 Finland

Liver transplant status

8.2

22.0

K73.2

ICD-10 Finland

Chronic active hepatitis, not elsewhere classified

7.9

21.9

J01FA10

ATC

azithromycin; systemic

1.3

21.8

3647

32206

K56.0

ICD-10 Finland

Paralytic ileus

4.9

21.6

146

UJH02

NOMESCO Finland

Anoscopy

2.2

21.5

232

1091

M01AE01

ATC

ibuprofen; systemic, rectal

0.7

21.3

5284

56228

K74.3

ICD-10 Finland

Primary biliary cirrhosis

7.1

21.3

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.6

21.1

554

3533

WW200

NOMESCO Finland

Immunization

2.4

21.1

190

821

5550A

ICD-9 Finland

Regional enteritis, Small intestine

50.1

21.1

ZXD05

NOMESCO Finland

Urgent procedure

1.3

20.8

1751

14061

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.8

20.6

343

1911

JL5CG

NOMESCO Finland

Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet

4.5

20.3

161

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

19.9

2198

18313

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.5

19.7

154

621

A07AA02

ATC

nystatin; oral

1.9

19.6

286

1522

5604

FHL

Vascular preparation or cannulation in the operating room

10.9

19.6

JJC00

NOMESCO Finland

Allogenic transplantation of liver

10.3

19.6

1300

FHL

Esophagogastroduodenoscopy (also includes staining)

4.4

19.5

163

JFH00

NOMESCO Finland

Total colectomy and ileorectal anastomosis

13.8

19.5

SPAT1131

SPAT

Colonoscopy

2.4

19.4

164

688

Y0599

ICD-8 Finland

Investigation of digestive system

3.2

19.2

101

317

SPAT1263

SPAT

Sampling

1.3

18.7

2395

20302

5559X

ICD-9 Finland

Regional enteritis, Unspecified site

190.5

18.5

D99

ICPC

Disease digestive system other

3.9

18.5

201

R01AD08

ATC

fluticasone; nasal

1.3

18.5

1635

13182

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.6

18.1

472

3006

UJF32

SPAT

3.1

17.8

324

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.0

17.7

220

1100

E86

ICD-10 Finland

Volume depletion

2.8

17.7

113

405

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.6

17.7

452

2866

JFF11

NOMESCO Finland

Laparoscopic loop enterostomy

8.2

17.7

K52.80

ICD-10 Finland

(Hemorrhagic) colitis caused by antibiotics

10.3

17.6

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

4.0

17.6

176

K83.9

ICD-10 Finland

Disease of biliary tract, unspecified

7.0

17.6

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

2.7

17.6

118

437

D07AD01

ATC

clobetasol; topical

1.4

17.2

761

5457

Z43.2

ICD-10 Finland

Attention to ileostomy

10.4

17.1

JKE32

NOMESCO Finland

Endoscopic dilatation of bile duct

8.1

16.7

JGB61

NOMESCO Finland

Laparoscopic excision of rectum and ileoanal anastomosis

+∞

16.7

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

16.7

1881

15636

J05AB01

ATC

aciclovir; systemic

1.4

16.6

1061

8123

L88

ICD-10 Finland

Pyoderma gangrenosum

10.0

16.4

Z3231

NOMESCO Finland

Registered nurse

1.3

16.4

1426

11444

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

3.7

16.3

189

D07AC13

ATC

mometasone; topical

1.3

16.2

1523

12348

B03BA03

ATC

hydroxocobalamin; parenteral

1.9

16.1

235

1252

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.6

16.0

431

2768

A02BA02

ATC

ranitidine; systemic

1.4

15.8

867

6465

JHW96

NOMESCO Finland

Other operation on anus or perianal tissue

5.2

15.8

JFA38

NOMESCO Finland

Endoscopic dilatation of small intestine

14.5

15.8

M46.1

ICD-10 Finland

Sacroiliitis, not elsewhere classified

2.9

15.6

315

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

3.8

15.5

172

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

15.5

1832

15291

M07.4

ICD-10 Finland

Arthropathy in Crohn disease [regional enteritis]

13.7

15.5

R74.0

ICD-10 Finland

Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]

2.8

15.3

100

365

JHD20

NOMESCO Finland

Incision of fistula-in-ano

3.2

15.3

242

SPAT1255

SPAT

Intravenous administration of medicine

1.7

15.2

316

1888

L01BB01

ATC

11.2

15.2

JKD20

NOMESCO Finland

Anastomosis of bile duct to jejunum

16.1

15.2

D64.9

ICD-10 Finland

Anaemia, unspecified

1.6

15.1

386

2445

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.2

15.1

2351

20254

ICD-10 Finland

2.4

15.0

129

547

TPH07

NOMESCO Finland

Cathetrisation of artery

1.6

15.0

445

2928

JKE02

NOMESCO Finland

Transduodenal endoscopic incision of common bile duct orifice

3.3

14.8

232

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

3.3

14.8

232

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

9.7

14.6

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.0

14.6

186

944

6522

FHL

Ileostomy

+∞

14.6

J05AB11

ATC

valaciclovir; oral

1.4

14.6

636

4543

E000001

ATC

1.3

14.3

1112

8759

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

5.8

14.1

R01AD12

ATC

fluticasone furoate; nasal

1.3

14.1

1734

14506

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.7

14.1

279

1646

K62.4

ICD-10 Finland

Stenosis of anus and rectum

7.5

13.9

J02AC01

ATC

fluconazole; systemic

1.2

13.8

2103

18026

K83.1

ICD-10 Finland

Obstruction of bile duct

3.4

13.8

201

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.6

13.8

354

2246

J01CA04

ATC

amoxicillin; systemic

1.2

13.7

5155

48523

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

3.7

13.7

161

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.6

13.6

101

399

JFH31

NOMESCO Finland

Laparoscopic total colectomy, mucosal proctectomy and ileoanal anastomosis without ileostomy

+∞

13.5

WZC30

NOMESCO Finland

Teaching

1.4

13.5

618

4454

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

13.4

331

2078

6403

FHL

Ileocal resection

25.8

13.3

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

2.0

13.3

167

842

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.5

13.2

446

3024

J01FA06

ATC

roxithromycin; oral

1.2

13.0

2126

18335

B80

ICPC

Iron deficiency anaemia

2.4

13.0

108

454

JFG50

NOMESCO Finland

Laparotomy with revision of enterostomy or colostomy

16.7

13.0

A07AA11

ATC

rifaximin; oral

9.3

12.9

D29

ICPC

Digestive symptom/complaint other

2.4

12.9

107

449

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.6

12.6

329

2099

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.4

12.6

649

4783

6437

FHL

Rectum resection and sphincter-sparing through-anastomosis

+∞

12.5

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

12.5

1439

11921

D01

ICPC

Abdominal pain/cramps general

1.4

12.5

556

3989

K52.1

ICD-10 Finland

Toxic gastroenteritis and colitis

20.0

12.4

JHD33

NOMESCO Finland

Completing incision of fistula-in-ano

5.4

12.3

J01DA01

ATC

[U] cefalexin; systemic

1.2

12.2

3636

33208

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.5

12.2

432

2958

JFA76

NOMESCO Finland

Closure of fistula of small intestine

37.6

12.2

A98

ICPC

Health maint/preventive medicine

1.4

12.2

6486

63156

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.8

12.1

194

1073

R01AD09

ATC

mometasone; nasal

1.2

12.1

2584

22863

J01AA02

ATC

doxycycline; systemic

1.2

12.1

4473

41686

JD1AB

NOMESCO Finland

Gastro-duodenography with X-ray

26.7

12.0

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.5

11.9

475

3335

XJW99

NOMESCO Finland

Other investigative procedure on digestive system

5.2

11.9

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

2.6

11.9

334

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

2.1

11.8

136

664

N82.3

ICD-10 Finland

Fistula of vagina to large intestine

10.5

11.7

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.5

11.7

420

2886

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.7

11.6

235

1399

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

1.9

11.6

158

826

RD210

NOMESCO Finland

2.2

11.5

112

510

K73.9

ICD-10 Finland

Chronic hepatitis, unspecified

5.3

11.4

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

1.9

11.4

152

789

D07XC01

ATC

betamethasone, combinations; topical

1.4

11.3

558

4083

1470

FHL

Rectoscopy

3.6

11.1

133

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.3

11.0

1112

9046

M13.9

ICD-10 Finland

Arthritis, unspecified

1.5

11.0

348

2329

M03BC51

ATC

orphenadrine, combinations; systemic

1.2

10.9

1474

12412

L04AB02

ATC

infliximab; parenteral

43.4

10.9

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

2.3

10.9

416

B02.9

ICD-10 Finland

Zoster without complication

1.7

10.9

223

1333

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

2.7

10.9

257

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

1.9

10.9

155

826

B01AB10

ATC

tinzaparin; parenteral

1.6

10.8

291

1870

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.6

10.8

259

1619

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.2

10.7

1753

15060

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

2.1

10.7

120

582

JGB96

NOMESCO Finland

Other proctectomy or excision of rectum

12.9

10.6

L52

ICD-10 Finland

Erythema nodosum

3.7

10.6

123

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

2.3

10.5

412

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1663

1902

10.86

307.65

1.7

1.6

iu/ml

3.7

5.6

0.16

359

393

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

7211

45327

9.57

307.65

17.5

7.0

u/l

75.0

76.3

1.96

7099

42935

(3013650) Neutrophils [#/volume] in Blood by Automated count

6326

35199

5.35

307.65

15.3

9.1

e9/l

3.9

4.1

10.14

5908

30822

(3018010) Neutrophils/100 leukocytes in Blood

5743

29468

4.67

307.65

13.0

5.8

57.0

56.7

1.38

5551

27771

(3013707) Erythrocyte sedimentation rate by Westergren method

6650

44674

4.46

307.65

7.3

3.7

mm/h

11.3

10.3

8.33

6342

41823

(3025941) Bacteria identified in Stool by Culture

1339

3702

4.16

307.65

1.5

1.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

435

535

8.56

307.65

2.1

1.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

2207

9118

2.99

307.65

1.5

1.7

—

(3021440) Promyelocytes/100 leukocytes in Blood

1661

4595

4.33

307.65

6.2

4.2

0.1

0.2

2.52

431

1211

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

848

1263

7.42

307.65

3.3

6.1

iu/ml

836.6

784.4

0.07

176

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

327

179.65

307.65

3.2

2.8

mg/l

23.2

16.2

2.13

310

(3022096) Basophils/100 leukocytes in Blood

5645

27773

4.81

307.65

13.7

6.0

0.7

23.09

5444

26057

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

824

161

57.15

307.65

3.3

3.6

mg/l

8.6

7.2

2.33

688

116

(3024561) Albumin [Mass/volume] in Serum or Plasma

6051

23524

8.19

307.65

9.5

4.8

g/l

37.0

36.2

30.48

5867

21945

(40760892) CBC W Ordered Manual Differential panel - Blood

3108

14571

2.89

307.65

10.0

4.2

—

(3017181) Myelocytes/100 leukocytes in Blood

1724

4825

4.31

307.65

6.1

4.2

0.7

0.9

4.10

460

1307

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

728

1215

6.51

307.65

4.9

3.6

56.9

57.0

0.05

728

1215

(3025159) Blasts/100 leukocytes in Blood

1592

4363

4.33

307.65

6.3

4.3

0.0

0.2

1.08

370

1008

(42870588) Differential panel, method unspecified - Blood

4814

20248

4.64

307.65

11.9

5.9

—

(3022145) Colonoscopy Study observation

4922

5902

21.14

307.65

2.1

1.2

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3735

20924

2.52

307.65

4.9

3.2

u/l

30.0

34.3

4.11

3430

19963

(3002179) Metamyelocytes/100 leukocytes in Blood

1645

4422

4.45

307.65

5.7

4.0

0.3

0.6

6.55

348

946

(3006504) Eosinophils/100 leukocytes in Blood

5711

28682

4.77

307.65

13.6

6.0

2.8

2.9

0.40

5516

26873

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

5398

23613

5.24

307.65

3.7

2.2

nmol/l

74.7

74.5

0.18

5226

21693

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

346

191

18.92

307.65

2.4

1.9

mg/l

9.4

9.3

0.08

294

153

(3002030) Lymphocytes/100 leukocytes in Blood

5776

29915

4.66

307.65

13.7

6.0

28.7

28.8

0.24

5578

28077

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2487

3594

9.72

307.65

2.2

1.6

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

713

155

50.56

307.65

2.8

3.0

au/ml

122.2

149.9

0.23

101

(3001604) Monocytes [#/volume] in Blood

6109

30592

5.72

307.65

13.5

5.8

e9/l

0.6

3.15

5695

26674

(3019198) Lymphocytes [#/volume] in Blood

6147

31673

5.56

307.65

13.6

5.9

e9/l

1.9

2.0

8.63

5774

28196

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

3556

13720

3.94

307.65

3.9

2.1

mg/l

2.8

0.15

3237

11805

(3006315) Basophils [#/volume] in Blood

6123

30702

5.75

307.65

13.6

5.9

e9/l

0.0

4.38

5717

26760

(3021589) Normoblasts [#/volume] in Blood

4735

27340

2.88

307.65

16.6

8.8

e9/l

0.0

2.31

4223

22388

(3013115) Eosinophils [#/volume] in Blood

6197

31799

5.75

307.65

13.7

6.1

e9/l

0.2

2.36

5800

28206

(3007566) Smooth muscle Ab [Titer] in Serum

879

1735

5.59

307.65

1.8

1.2

titre

66.1

138.5

1.38

165

(3048689) Calprotectin [Mass/mass] in Stool

6162

7566

35.95

307.65

7.5

1.8

ug/g

237.9

107.7

75.89

5902

5910

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

317

173.92

307.65

3.2

2.8

—

(3034770) Mitochondria Ab [Titer] in Serum

864

1710

5.56

307.65

1.7

1.2

titre

462.9

935.3

—

(3019069) Monocytes/100 leukocytes in Blood

5736

28841

4.81

307.65

13.9

6.2

8.7

8.5

7.92

5544

27203

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

250

158

16.32

293.61

2.0

1.6

au/ml

86.4

167.9

0.75

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2558

12635

2.53

292.90

1.6

1.7

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

4425

27868

2.37

292.08

3.9

2.8

ug/l

97.3

115.7

5.23

4227

26193

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1762

7415

2.78

277.52

2.7

2.6

22.4

23.9

3.70

1540

6424

(3028026) IgM [Mass/volume] in Serum or Plasma

1120

3648

3.42

276.39

2.0

1.8

g/l

1.2

1.3

0.65

1054

3368

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

4549

29831

2.27

261.11

7.8

6.1

umol/l

10.9

11.2

1.01

4370

28294

(3005719) IgG [Mass/volume] in Serum or Plasma

1279

4747

3.03

252.14

2.8

2.6

g/l

11.7

10.5

21.93

1195

4356

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1801

8003

2.63

252.00

2.7

2.5

g/l

2.4

5.59

1714

7462

(3022948) Iron [Moles/volume] in Serum or Plasma

1907

8724

2.57

251.17

2.7

2.5

umol/l

13.4

13.9

1.97

1821

8151

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

348

481

7.53

238.65

1.5

1.2

titre

292.6

207.7

0.92

136

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

347

481

7.51

237.35

1.5

1.2

titre

383.2

178.2

0.63

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1316

5141

2.88

235.28

3.6

2.3

g/l

0.2

8.57

1244

4806

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

541

1189

4.82

229.28

1.6

1.3

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

157

25.42

224.71

1.0

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

7461

63751

5.65

220.45

25.0

12.2

mg/l

15.4

22.7

120.04

6648

49572

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3069

18277

2.12

210.55

4.0

2.6

u/l

60.1

56.8

2.29

2899

16964

(3024980) IgG subclass 4 [Mass/volume] in Serum

471

1033

4.79

199.70

2.3

1.6

g/l

0.8

0.04

387

785

(40768804) Tissue Pathology biopsy report

3694

23984

2.03

196.47

2.4

2.0

—

(3037522) Nuclear Ab [Titer] in Serum

1774

8734

2.34

192.53

1.7

1.3

titre

552.1

520.8

0.29

489

1633

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

561

1451

4.09

192.26

1.3

u/ml

271.8

256.1

0.52

322

939

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

580

1543

3.98

191.17

1.2

1.3

—

(40758558) Short blood count panel - Blood

2612

15207

2.08

184.89

10.3

7.0

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

558

1499

3.93

181.24

1.8

1.4

iu/ml

5.0

15.3

1.64

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

290

468

6.40

171.73

2.4

1.4

—

(3003327) Ova and parasites identified in Stool by Light microscopy

686

2261

3.23

162.58

1.8

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

625

1949

3.40

162.04

2.0

1.6

titre

379.3

414.5

0.11

(3007164) IgA [Mass/volume] in Serum or Plasma

2243

13018

2.02

154.90

1.8

1.4

g/l

2.5

2.3

2.78

1623

8294

(3014148) Varicella zoster virus Ab [Titer] in Serum

415

1007

4.30

154.40

1.1

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

335

690

5.03

152.62

1.7

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

331

679

5.05

151.50

1.7

1.4

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

700

2433

3.06

151.24

1.8

1.6

u/ml

5.7

15.7

1.97

(3024522) Salmonella sp identified in Specimen by Organism specific culture

330

677

5.05

151.02

1.7

1.4

—

(3032080) INR in Blood by Coagulation assay

3240

21483

1.87

148.84

8.5

7.9

inr

1.1

1.2

7.48

1159

6514

(42529406) Shigella sp [Presence] in Stool by Culture

565

1750

3.40

147.75

1.3

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

356

793

4.66

147.60

1.4

1.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

422

1077

4.09

146.67

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

561

1741

3.40

146.22

1.3

1.1

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

490

1396

3.68

145.62

1.4

1.3

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

557

1728

3.40

145.24

1.3

1.1

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

321

673

4.93

143.16

1.7

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

320

671

4.93

142.68

1.7

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

320

675

4.90

141.68

1.7

1.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

701

2550

2.92

139.29

1.3

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

6875

59022

2.47

139.01

19.7

11.0

ml/min/173m2

90.0

87.8

15.45

6020

48550

(46235355) HIV 1 and 2 tests - Meaningful Use set

2537

15865

1.89

137.32

1.8

2.0

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

527

1701

3.25

128.57

5.6

3.5

u/ml

51.6

3257.0

1.25

481

1458

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3759

26899

1.77

127.82

6.9

6.8

mmol/l

1.2

1.61

3140

22776

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

267

539

5.09

124.35

1.3

1.2

u/l

57.3

61.8

0.42

182

366

(3002385) Erythrocyte distribution width [Ratio]

6399

54197

2.04

120.36

26.5

14.8

13.7

13.5

13.15

6365

53091

(40768441) Liver Pathology biopsy report

231

427

5.55

118.70

1.7

1.5

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

664

2555

2.75

118.14

1.2

1.4

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

7476

67945

3.89

117.83

22.1

9.2

u/l

27.3

28.1

2.67

7413

65891

(40761536) Microorganisms panel - Urine sediment

1068

5193

2.23

113.93

4.2

3.5

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3410

24374

1.71

111.04

6.1

6.2

mmol/l

1.2

3.21

3149

22297

(3037467) Urinalysis macro (dipstick) panel - Urine

5183

41581

1.75

109.46

4.6

3.9

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

102

13.41

108.29

2.4

1.8

mg/l

2.1

1.4

2.86

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

20.98

107.63

1.1

u/ml

26.0

41.9

0.49

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

20.98

107.63

1.1

u/ml

20.1

26.9

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

150

197

7.74

107.22

1.8

u/ml

4513.1

18235.1

0.40

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1878

11389

1.86

107.19

2.4

1.6

pmol/l

35807264.0

31640645.6

0.11

1698

9706

(3018418) pH of Serum or Plasma

2408

15872

1.75

103.19

4.1

7.4

0.22

500

3143

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1101

5620

2.12

103.13

3.5

2.5

u/l

40.1

45.8

0.29

986

4851

(3023368) Bacteria identified in Blood by Culture

2242

14482

1.77

103.09

4.7

4.3

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1271

6853

2.02

102.60

4.2

2.8

umol/l

6.6

7.8

1.84

1122

5948

(3010375) cycloSPORINE [Mass/volume] in Blood

179

299

6.10

102.25

17.0

26.3

ug/l

133.6

116.4

2.14

163

237

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

312

867

3.71

95.76

1.1

g/l

1.5

0.68

291

779

(3019309) Folate [Moles/volume] in Red Blood Cells

1536

9031

1.87

95.22

2.1

1.7

nmol/l

1176.4

1161.6

0.22

1024

7014

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

172

316

5.54

88.93

1.4

1.2

u/l

78.8

90.1

0.73

141

273

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

171

313

5.56

88.77

1.8

1.5

u/l

5.0

5.6

0.19

154

(3033658) Prothrombin time (PT) actual/Normal

2263

15167

1.70

88.51

5.9

3.9

94.0

92.1

3.31

2204

14789

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

167

305

5.57

86.90

1.4

1.2

u/l

21.5

20.9

0.04

138

259

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1095

6004

1.96

82.83

1.3

1.5

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2196

14836

1.67

82.13

1.3

u/ml

1.5

1.8

0.40

554

4178

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2966

21656

1.60

80.74

2.0

1.9

pmol/l

96.1

96.6

0.21

1769

11697

(3023103) Potassium [Moles/volume] in Serum or Plasma

7003

63432

2.09

78.71

18.6

13.7

mmol/l

3.9

4.0

37.55

6845

61671

(3019550) Sodium [Moles/volume] in Serum or Plasma

6983

63189

2.07

78.64

18.5

13.6

mmol/l

139.5

139.7

12.48

6836

61564

(3004716) Salmonella sp identified in Stool by Organism specific culture

735

3592

2.16

75.81

1.5

1.4

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

906

4861

1.98

72.38

5.1

4.2

ug/l

8.9

31.3

2.11

702

3860

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

186

435

4.36

72.33

1.2

—

(3004809) Band form neutrophils/100 leukocytes in Blood

281

878

3.28

71.85

3.1

3.3

0.8

1.4

3.99

210

680

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

185

439

4.29

70.60

1.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

116

189

6.22

67.95

1.2

1.3

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

193

489

4.02

67.48

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

184

451

4.15

67.29

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

184

456

4.11

66.30

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

422

1722

2.53

65.88

1.2

1.3

—

(40768797) Stomach Pathology biopsy report

1281

7876

1.75

65.87

1.3

1.2

—

(3009261) Glucose [Presence] in Urine by Test strip

3787

30084

1.51

65.76

3.8

3.3

estimate

0.0

0.51

1116

5500

(3017732) Neutrophils [#/volume] in Blood

806

4288

1.98

65.66

2.9

2.7

e9/l

4.2

0.04

585

3516

(3013826) Glucose [Moles/volume] in Serum or Plasma

4205

34183

1.50

64.96

5.3

4.7

mmol/l

6.6

0.37

3947

31666

(3035350) Ketones [Presence] in Urine by Test strip

3748

29764

1.50

64.83

3.8

3.3

estimate

0.0

1.28

1115

5515

(3021601) Nitrite [Presence] in Urine by Test strip

3748

29803

1.50

64.17

4.9

4.4

estimate

0.0

0.80

1143

5717

(3029937) Albumin [Presence] in Urine by Test strip

2215

15748

1.57

64.01

4.2

3.6

estimate

0.0

0.10

1117

5475

(40761511) CBC panel - Blood by Automated count

7217

67099

2.11

60.03

18.9

11.3

—

(3041096) Erythrocytes [Presence] in Urine by Automated

2316

16950

1.52

57.37

3.6

2.9

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

365

1486

2.53

57.18

1.3

1.5

u/ml

14.3

20.6

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

281

1011

2.85

56.20

5.3

3.7

u/ml

117.9

584.0

1.11

257

935

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

363

1493

2.50

55.64

1.3

1.5

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

969

5789

1.77

54.25

2.3

2.2

nmol/l

327.4

372.4

11.91

900

5325

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

339

1366

2.55

54.24

1.3

1.5

u/ml

108.7

111.3

0.18

260

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3003

23366

1.47

54.17

4.0

3.3

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

105

7.40

53.29

1.4

1.2

—

(3041672) Baker's yeast Ab [Presence] in Serum

13.13

49.36

1.1

1.0

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

143

370

3.92

48.62

1.1

miu/ml

1596.0

1457.9

0.69

143

370

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

177

529

3.40

48.61

1.1

mg/l

283.7

283.8

0.01

159

481

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

269

1040

2.64

46.82

2.7

3.0

u/ml

960.0

1142.8

0.12

(3021960) Folate [Moles/volume] in Serum or Plasma

1667

11810

1.52

46.37

1.6

1.5

nmol/l

20.1

20.2

0.12

1491

10328

(3017354) Segmented neutrophils/100 leukocytes in Blood

173

529

3.32

45.83

3.1

3.3

58.7

56.8

0.48

106

334

(3052851) Hemolysis interference index of Serum or Plasma

374

1702

2.26

45.54

3.3

3.0

—

(3027945) Reticulocytes/100 erythrocytes in Blood

912

5663

1.69

43.88

3.8

2.7

1.8

1.49

830

5063

(3007461) Platelets [#/volume] in Blood

7532

72231

2.56

41.83

34.0

17.8

e9/l

271.4

253.3

91.16

7481

70587

(3035941) MCH [Entitic mass]

7533

72294

2.53

40.88

33.7

17.7

30.4

30.2

12.98

7506

71445

(3024731) MCV [Entitic volume]

7533

72300

2.53

40.76

33.8

17.7

91.3

90.4

60.83

7506

71454

(3026361) Erythrocytes [#/volume] in Blood

7533

72312

2.52

40.53

33.9

17.8

e12/l

4.5

4.6

28.35

7467

70532

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

219

4.52

40.47

1.5

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

219

4.52

40.47

1.5

1.4

—

(3010813) Leukocytes [#/volume] in Blood

7534

72334

2.53

40.38

34.0

17.8

e9/l

6.8

6.7

4.28

7469

70521

(3000963) Hemoglobin [Mass/volume] in Blood

7533

72338

2.51

40.03

34.1

17.9

g/l

136.3

137.9

18.62

7505

71479

(3042936) Bacteria identified in Isolate by Culture

1214

8265

1.56

39.82

2.2

2.1

—

(3008898) HLA-B27 [Presence]

491

2612

1.94

39.39

1.1

—

(3031040) Bacteria [#/volume] in Urine by Automated count

4499

38884

1.37

39.18

4.3

3.9

e6/l

1281.6

1236.7

0.01

490

(3014576) Chloride [Moles/volume] in Serum or Plasma

1034

6814

1.60

38.99

8.7

7.6

mmol/l

104.8

104.5

1.84

1019

6662

(4035726)

771

4723

1.70

38.78

1.4

—

(3032057) Clostridioides difficile [Presence] in Stool

6.60

38.17

2.2

2.0

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

258

1080

2.44

38.04

1.2

titre

146.7

222.7

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

103

256

4.06

37.08

1.2

1.1

u/l

13.2

24.7

3.29

204

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

110

289

3.85

36.68

1.4

1.3

—

(3023520) Reticulocytes [#/volume] in Blood

677

4073

1.73

36.28

2.9

2.7

e9/l

74.6

70.8

1.47

521

3034

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

353

1719

2.10

36.22

4.0

4.1

mg/l

1.3

1.4

1.28

325

1606

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

102

257

4.01

36.06

1.2

1.1

u/l

66.1

90.8

2.55

212

(3008757) Leukocyte morphology finding [Identifier] in Blood

162

550

2.99

36.05

3.5

3.9

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

110

298

3.73

35.13

1.4

1.3

—

(3002582) Erythrocytes [#/volume] in Urine

2211

17330

1.39

34.06

3.4

3.1

e6/l

78.4

91.1

0.20

1798

13220

(3020961) Endomysium IgA Ab [Titer] in Serum

558

3252

1.77

33.37

1.1

titre

48.6

183.0

—

(3030467) Casts [#/volume] in Urine by Automated count

2042

15849

1.39

33.21

3.3

3.0

e6/l

0.4

0.3

0.60

1618

11839

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1055

7249

1.53

32.65

6.2

6.6

mmol/l

1.0

1.57

996

6819

(3016650) Hepatitis A virus Ab [Presence] in Serum

257

1164

2.25

31.66

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

233

3.94

31.51

1.7

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3375

28479

1.33

31.36

4.7

3.9

—

(36304419) Bacteria [Presence] in Urine

2001

15632

1.38

30.86

3.1

2.9

—

(3044640) Blood type and Crossmatch panel - Blood

2332

18667

1.36

30.81

2.8

2.3

—

(3026782) Osmolality of Urine

1483

11086

1.42

29.48

2.9

2.7

mosm/kgh2o

554.7

556.4

0.10

1320

9486

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

254

3.69

29.41

1.2

—

(3018095) Leukocytes [#/volume] in Urine

2527

20594

1.34

29.28

3.8

3.5

e6/l

73.4

76.9

0.06

1911

14341

(3000850) Epithelial cells [#/volume] in Urine

1579

11955

1.40

29.13

2.7

2.5

e6/l

5.8

5.6

0.14

1425

10506

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

204

4.00

28.72

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

247

1152

2.18

28.34

1.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

669

4378

1.58

25.46

3.9

mmol/l

1.2

0.41

595

3859

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

821

5627

1.51

25.33

3.2

—

(4062490)

166

688

2.44

25.12

1.3

1.4

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

165

687

2.43

24.72

1.2

1.4

g/l

0.4

0.05

485

(3027135) IgG subclass 1 [Mass/volume] in Serum

165

687

2.43

24.72

1.2

1.4

g/l

8.2

6.6

4.53

101

484

(3020779) Urea [Moles/volume] in Serum or Plasma

733

4929

1.54

24.69

9.0

8.5

mmol/l

8.5

9.1

1.47

695

4732

(3020393) Adenovirus Ag [Presence] in Stool

6.48

24.68

1.8

1.3

—

(3009542) Hematocrit [Volume Fraction] of Blood

6497

61070

1.40

24.68

22.2

12.9

40.3

40.7

3.54

4901

48055

(3028192) IgG subclass 2 [Mass/volume] in Serum

165

688

2.43

24.65

1.2

1.4

g/l

3.0

0.05

488

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1722

13553

1.35

24.34

1.9

1.8

mg/l

1.1

0.51

1330

10103

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

150

4.23

24.13

1.3

1.2

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

2223

18224

1.31

23.47

3.3

mmol/l

2.3

0.74

1981

16248

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

129

490

2.66

23.41

1.2

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1214

9105

1.40

23.08

4.2

3.7

mmol/l

0.8

5.92

1124

8570

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

5023

45668

1.28

23.06

4.5

3.0

u/l

53.4

44.9

8.59

4765

43332

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1154

8625

1.40

22.33

2.0

1.8

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1324

10123

1.37

22.31

1.3

u/ml

6.6

10.5

1.96

471

4170

(3052592) Norovirus Ag [Presence] in Stool

5.20

21.21

1.9

1.4

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

293

1612

1.85

21.17

1.6

1.4

ug/g

283.3

286.1

0.08

177

909

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1765

14189

1.32

21.08

2.7

2.2

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

297

2.99

19.97

2.0

1.8

umol/l

2.1

1.9

0.60

280

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

241

3.17

19.19

3.6

2.8

—

(3026008) Bacteria identified in Urine by Culture

1851

15153

1.29

18.98

2.9

2.7

—

(3019225) pH of Specimen

720

5116

1.45

18.31

3.8

4.0

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2426

20606

1.26

18.25

3.4

3.2

ng/l

46.1

54.1

0.28

1487

12303

(3002032) Base excess in Venous blood by calculation

700

4963

1.45

18.00

5.0

4.1

mmol/l

1.7

1.8

0.25

553

4034

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1360

10756

1.32

17.88

1.3

iu/ml

23.1

31.4

1.20

416

3300

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

315

1904

1.68

16.49

1.1

u/ml

2.6

5.6

1.36

280

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

364

2285

1.62

16.44

1.9

1.8

g/l

1.4

1.5

0.47

320

1974

(3007853) Bacteria identified in Skin by Aerobe culture

950

7210

1.36

16.39

1.8

1.7

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

690

4980

1.42

16.06

5.1

4.1

kpa

5.8

0.01

662

4830

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

814

6076

1.38

15.55

3.8

4.5

u/l

224.4

238.2

3.19

771

5768

(36660697) Celiac disease serology panel - Serum

718

5316

1.39

14.38

1.2

—

(3022217) INR in Platelet poor plasma by Coagulation assay

840

6388

1.35

14.21

20.5

20.3

inr

1.2

1.3

0.31

169

978

(3015171) Extractable nuclear Ab [Units/volume] in Serum

376

2468

1.55

14.07

1.3

1.2

u/ml

0.3

1.1

2.93

219

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1195

9605

1.29

13.59

2.8

2.6

e6/l

0.9

1.1

0.43

710

5355

(3028433) Virus identified in Specimen by Culture

195

2.99

13.38

1.2

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

310

1971

1.60

13.33

1.5

1.7

g/l

1.2

0.01

292

1871

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1124

8988

1.29

13.28

3.0

2.8

e6/l

2.3

2.4

0.17

640

4756

(3000494) Fungus identified in Specimen by Culture

916

7145

1.32

12.99

1.6

1.5

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

300

1905

1.60

12.98

1.5

1.7

g/l

0.2

1.70

281

1806

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

768

5845

1.35

12.89

1.9

1.7

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

389

2.33

12.62

3.1

2.6

92.4

95.8

0.46

364

(3020717) Zinc [Moles/volume] in Serum or Plasma

347

2.41

12.54

1.5

umol/l

26.6

25.1

0.16

332

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

228

1363

1.69

12.52

1.8

1.6

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

773

5916

1.34

12.49

1.9

1.7

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

5121

47952

1.20

12.45

3.3

—

(3000991) Gas panel - Venous blood

628

4663

1.38

12.33

9.6

9.2

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

386

2624

1.50

12.29

1.8

2.0

u/l

38.5

39.5

0.46

339

2380

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

301

1947

1.57

12.06

1.9

—

(40768443) Skin Pathology biopsy report

363

2463

1.50

11.68

1.2

—

(40767503) Oxygen content in Capillary blood by calculation

199

1170

1.72

11.65

2.3

2.5

17.0

16.8

0.26

101

566

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

397

2752

1.47

11.48

5.3

4.5

mmol/l

24.0

24.1

0.39

369

2480

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

121

618

1.97

11.14

1.0

1.1

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

487

3528

1.41

11.08

7.9

7.7

mmol/l

24.5

24.8

0.98

480

3508

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

511

3773

1.38

10.39

4.0

4.2

ng/l

87.6

90.1

0.21

457

3340

(3034274) Bile acid [Moles/volume] in Serum --fasting

180

1069

1.70

10.21

2.3

umol/l

13.2

6.5

1.94

140

780

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

194

2.69

10.01

2.0

3.0

—

(3004588) Protein electrophoresis panel - Serum or Plasma

444

3226

1.40

9.95

2.4

2.2

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

297

2001

1.50

9.93

2.0

ug/l

7.2

2.2

0.51

263

1799

(3042733) HLA Ab [Presence] in Serum

256

2.43

9.72

3.0

5.0

—

(3051651) Icteric interference index of Serum or Plasma

357

2.20

9.66

4.5

3.6

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

612

4701

1.33

9.62

2.9

2.5

ml/min/173m2

71.9

71.6

0.05

256

1771

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1689

14588

1.20

9.61

1.7

1.6

—

(3013512) EKG study

1750

15181

1.20

9.47

3.4

—

(3051611) Lipemic interference index of Serum or Plasma

104

537

1.95

9.35

4.3

3.3

—

(3020630) Protein [Mass/volume] in Serum or Plasma

534

4040

1.35

9.31

2.5

g/l

67.5

66.8

1.15

507

3741

(3024354) Oxygen [Partial pressure] in Venous blood

536

4066

1.34

9.18

4.4

3.5

kpa

4.5

4.7

1.88

512

3929

(3012501) Base excess in Blood by calculation

208

1319

1.59

9.16

3.3

4.1

mmol/l

2.4

0.04

136

877

(3013290) Carbon dioxide [Partial pressure] in Blood

208

1320

1.59

9.14

3.3

4.2

kpa

5.0

0.65

202

1300

(3027315) Oxygen [Partial pressure] in Blood

208

1326

1.58

8.97

3.3

4.2

kpa

8.9

8.8

0.22

202

1305

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

198

1249

1.60

8.93

1.2

1.3

u/ml

5.2

6.4

0.13

(1616796) Gas panel - Central venous blood

198

1250

1.60

8.90

3.3

3.7

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

457

3411

1.36

8.71

4.8

3.6

kpa

5.0

5.1

2.65

422

3171

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

245

2.38

8.70

2.8

3.3

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

209

1346

1.57

8.64

1.9

1.6

—

(40760888) Immunoglobulin light chains.free panel - Serum

171

1050

1.64

8.61

3.0

3.5

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

640

5023

1.30

8.61

8.5

9.0

g/l

121.5

123.5

1.62

616

4841

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

249

1668

1.51

8.61

2.6

—

(3010421) pH of Blood

232

1531

1.53

8.61

3.2

4.2

7.4

0.04

202

1300

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1106

9256

1.23

8.60

3.2

2.9

mmol/l

2.4

1.49

964

8098

(3009343) pH of Capillary blood

450

3364

1.36

8.50

4.8

3.6

7.4

0.82

409

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

160

970

1.66

8.48

1.9

1.7

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

121

2.98

8.44

3.4

3.2

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

206

1336

1.56

8.28

4.6

3.2

mmol/l

24.0

24.5

1.01

177

1164

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

250

1698

1.49

8.11

3.6

u/ml

0.3

0.04

141

956

(3016502) Oxygen saturation in Arterial blood

677

5403

1.28

8.00

8.2

8.5

96.6

95.9

3.11

647

5207

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

5.17

7.92

1.0

1.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

387

2.03

7.92

1.7

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

210

1383

1.53

7.90

3.3

3.4

mg/l

46.9

54.9

0.54

164

1109

(3028626) Oxygen [Partial pressure] in Capillary blood

195

1266

1.55

7.83

6.2

3.5

kpa

8.6

0.27

179

1164

(3002256) Pathology report gross observation

910

7535

1.24

7.80

1.2

1.3

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

431

3245

1.35

7.79

4.8

3.6

mmol/l

1.4

1.6

0.49

315

2397

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

131

771

1.71

7.79

1.8

1.5

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

482

3690

1.33

7.78

1.0

1.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

252

1730

1.47

7.77

1.2

1.3

u/ml

20.3

32.2

0.34

105

(3011412) CD3 cells [#/volume] in Blood

115

654

1.77

7.72

1.8

2.4

e9/l

1.3

1.2

0.21

393

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

209

1383

1.53

7.70

3.3

3.4

mg/l

37.6

57.8

1.08

162

1112

(3003338) MCHC [Mass/volume]

5942

57151

1.17

7.66

27.1

15.2

g/l

332.3

333.6

24.06

5924

56746

(3001186) Copper [Moles/volume] in Serum or Plasma

168

2.57

7.65

1.4

1.3

umol/l

16.7

17.0

0.13

148

(3047181) Lactate [Moles/volume] in Blood

251

1728

1.47

7.63

5.9

6.6

mmol/l

1.3

0.25

223

1518

(3011397) Hemoglobin [Presence] in Urine by Test strip

1555

13592

1.18

7.50

3.5

3.3

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

292

2080

1.42

7.41

5.4

5.6

1.7

0.18

274

1939

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

230

1566

1.48

7.41

1.2

1.3

u/ml

8.0

5.0

0.36

154

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

166

1053

1.59

7.39

1.1

u/ml

2.2

3.4

1.50

551

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

274

1931

1.43

7.38

3.1

2.9

g/l

3.4

3.6

1.29

255

1833

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

202

1344

1.52

7.28

3.3

ratio

1.4

3.0

0.93

117

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

171

1099

1.57

7.21

1.5

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

151

943

1.61

7.18

1.4

—

(3011325) HIV 1+2 Ab [Presence] in Serum

4.48

7.17

1.0

1.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

274

2.16

7.16

1.6

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

274

2.16

7.16

1.6

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

274

2.16

7.16

1.6

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

274

2.16

7.16

1.6

1.9

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

231

1587

1.47

7.13

1.2

1.3

u/ml

12.5

9.5

0.33

244

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

313

2276

1.39

7.07

2.2

2.0

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

606

4847

1.27

7.04

7.9

7.7

mmol/l

1.3

1.4

0.05

583

4662

(3007930) Methemoglobin/Hemoglobin.total in Blood

288

2066

1.41

7.04

5.4

5.7

1.0

0.9

1.57

269

1930

(3024891) Influenza virus A+B Ag [Presence] in Specimen

262

1848

1.43

7.04

1.2

1.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

123

737

1.68

6.90

1.6

1.4

—

(3023183) Ammonium ion [Moles/volume] in Plasma

189

1256

1.52

6.87

3.7

3.0

umol/l

31.2

35.8

2.76

163

1090

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1012

8585

1.21

6.80

2.5

2.3

29.9

29.7

0.51

977

8339

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

291

2105

1.40

6.79

2.4

2.5

94.6

92.8

0.65

268

1961

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

5038

48033

1.14

6.78

3.7

3.8

pmol/l

14.7

14.6

3.36

4646

44338

(44816559) Phosphatidylethanol [Mass/volume] in Blood

224

1547

1.46

6.75

1.2

1.4

—

(3003396) Base excess in Arterial blood by calculation

734

6040

1.24

6.66

7.8

8.0

mmol/l

0.7

0.9

0.73

574

4704

(3036071) Salmonella sp Ab [Titer] in Serum

250

2.17

6.63

1.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

479

1.83

6.56

1.9

2.5

e6/l

464.0

526.7

0.63

396

(3021901) Oxygen saturation in Capillary blood

147

934

1.58

6.55

4.2

2.8

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

267

1917

1.41

6.52

2.7

2.8

179.2

181.3

0.15

252

1827

(3004616) Nuclear Ab [Presence] in Serum

119

719

1.67

6.49

1.3

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

467

1.83

6.46

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

467

1.83

6.46

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

467

1.83

6.46

1.6

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

326

2426

1.36

6.42

4.4

3.5

mmol/l

24.8

25.2

1.06

312

2347

(3026493) Urate [Moles/volume] in Serum or Plasma

1738

15495

1.16

6.40

2.8

2.5

umol/l

3847.0

3613.8

0.09

1565

13739

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

137

862

1.60

6.37

1.6

1.4

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

124

766

1.63

6.22

1.2

1.3

u/ml

5.8

53.4

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

729

6049

1.23

6.12

7.9

8.0

kpa

5.0

5.1

2.26

694

5783

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

154

1008

1.54

6.06

1.6

1.4

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

380

2919

1.32

6.05

11.2

11.1

—

(3027801) Oxygen [Partial pressure] in Arterial blood

728

6049

1.22

6.03

7.9

8.0

kpa

13.0

12.7

0.80

694

5785

(3005322) IgE [Units/volume] in Serum or Plasma

541

4352

1.26

6.02

1.3

u/ml

265.4

228.1

0.25

505

4040

(40761539) Cells [Type] in Urine sediment by Light microscopy

140

2.51

6.00

1.0

1.2

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

420

3279

1.30

5.95

6.4

7.5

mmol/l

24.2

24.4

0.54

391

3052

(3044889) 12 lead EKG panel

4375

41512

1.12

5.91

3.4

3.3

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

326

0.24

5.89

2.9

2.3

nmol/l

199.6

151.9

—

277

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1489

13198

1.16

5.88

3.1

3.0

ng/l

1475.7

1201.3

1.13

1233

11062

(3026389) Candida sp identified in Specimen by Organism specific culture

136

872

1.57

5.87

1.3

—

(3036489) Thrombin time

320

2411

1.34

5.84

2.3

21.3

0.08

279

2076

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

280

2067

1.37

5.83

2.1

1.8

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

234

1680

1.41

5.77

2.5

2.3

g/l

10.9

10.3

1.05

200

1447

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

231

1655

1.41

5.76

2.0

mg/l

10.6

10.7

0.08

213

1555

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

486

1.76

5.71

1.9

2.6

e6/l

755.2

732.3

0.10

188

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

250

1820

1.39

5.68

2.5

2.2

g/l

4.1

3.8

1.23

183

1325

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

465

1.77

5.67

1.8

2.5

e9/l

0.2

2.71

394

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

250

1821

1.39

5.67

2.5

2.2

g/l

7.1

7.3

0.72

187

1390

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

250

1821

1.39

5.67

2.5

2.2

—

(3024471) HLA-A [Type]

247

2.07

5.64

1.0

—

(3037756) Immunofixation for Serum or Plasma

140

917

1.54

5.53

2.0

1.6

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

5912

57233

1.14

5.49

4.4

4.5

mu/l

1.7

2.2

4.74

5530

53333

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

104

636

1.64

5.48

2.0

1.6

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

297

2238

1.34

5.44

4.8

3.9

46.5

50.5

2.07

292

2209

(3006184) Hemoglobin [Mass/volume] in Capillary blood

171

1173

1.47

5.42

2.4

2.2

g/l

131.5

132.5

0.21

137

858

(3003694) ABO and Rh group [Type] in Blood

2084

19001

1.13

5.38

1.6

1.5

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

415

1.79

5.34

2.0

1.6

—

(40761535) Cells panel - Urine sediment

545

4462

1.24

5.22

3.5

3.3

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

182

2.20

5.20

1.4

1.5

—

(1761482) Bacteria [#/volume] in Urine by Culture

170

1176

1.46

5.18

4.4

3.6

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1850

16785

1.13

5.13

2.2

u/l

221.7

223.8

0.02

1758

15874

(3024932) HLA-DR beta [Type]

243

2.02

5.12

1.0

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

3.76

5.08

1.3

1.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

407

3239

1.27

5.00

1.5

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

187

1327

1.42

4.98

1.2

1.3

u/ml

33.5

41.8

0.24

121

(21494815) CD4 cells/100 lymphocytes in Specimen

591

1.63

4.97

1.8

2.3

51.3

42.6

0.95

(3039000) Anion gap in Blood

172

1203

1.44

4.96

7.0

7.8

mmol/l

11.5

11.3

0.20

156

1077

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

163

1129

1.45

4.95

1.5

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

163

1129

1.45

4.95

1.5

1.3

—

(3018572) Chloride [Moles/volume] in Blood

172

1204

1.44

4.94

7.0

7.8

mmol/l

105.1

105.2

0.17

156

1078

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

993

8647

1.17

4.90

1.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

119

774

1.55

4.90

1.7

1.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1165

10272

1.16

4.89

1.5

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

361

2844

1.28

4.83

3.0

2.7

e6/l

0.4

0.2

0.56

350

2749

(3004119) Hemoglobin [Mass/volume] in Venous blood

402

3214

1.26

4.77

4.3

3.5

g/l

130.3

131.3

0.38

383

3141

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

152

1049

1.46

4.72

3.5

3.3

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

232

1724

1.36

4.71

2.6

2.2

g/l

3.1

0.11

186

1363

(3019150) Specific gravity of Urine by Refractometry

1446

13000

1.14

4.57

3.9

3.6

kg/l

1.0

0.29

195

1857

(3019060) Gas panel - Arterial blood

423

3435

1.24

4.41

4.8

5.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

456

1.67

4.39

1.9

1.8

—

(3014007) Fractional oxyhemoglobin in Arterial blood

421

3419

1.24

4.39

9.6

10.0

94.9

93.9

5.21

414

3408

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

154

1083

1.43

4.36

1.3

u/ml

4.5

4.3

0.12

480

(3038515) Glucose [Moles/volume] in Venous blood

137

945

1.46

4.31

3.6

2.9

mmol/l

7.6

7.3

0.35

132

921

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

281

1.86

4.30

1.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

100

650

1.55

4.19

1.7

1.6

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1182

10544

1.14

4.19

3.3

3.5

ng/l

656.3

574.9

0.16

806

7377

(3000330) Specific gravity of Urine by Test strip

321

2542

1.27

4.17

3.7

3.1

—

(3028707) Methadone [Presence] in Urine by Screen method

122

1766

0.69

4.16

1.7

3.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

174

2.07

4.10

1.5

ug/l

11.1

8.3

1.88

174

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

293

1.81

4.10

1.2

—

(3008037) Lactate [Moles/volume] in Venous blood

144

1015

1.43

4.06

3.6

2.8

mmol/l

1.5

1.6

0.04

139

985

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

419

5082

0.81

4.03

1.3

1.4

—

(4268621)

113

762

1.49

4.01

2.4

2.3

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

207

1554

1.34

3.99

2.7

2.3

g/l

1.1

0.8

0.37

181

1375

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

123

846

1.46

3.96

1.3

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

155

1117

1.40

3.87

1.3

u/ml

5.9

3.3

1.01

365

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

224

1713

1.32

3.82

1.6

1.8

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

254

1980

1.29

3.77

1.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

650

7525

0.85

3.75

1.5

1.7

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

129

906

1.43

3.74

2.6

2.5

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

548

1.56

3.74

2.7

2.3

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

365

2981

1.24

3.67

1.7

1.6

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

411

3399

1.22

3.66

9.8

10.0

0.7

0.23

406

3377

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

5.63

3.65

1.0

1.1

—

(3035285) Chloride [Moles/volume] in Venous blood

568

1.54

3.63

2.7

2.2

mmol/l

106.3

105.5

0.85

558

(3041354) Potassium [Moles/volume] in Venous blood

568

1.54

3.63

2.7

2.2

mmol/l

4.0

0.56

558

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

419

1.63

3.62

1.2

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

343

1.70

3.61

1.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

187

1410

1.33

3.55

2.6

2.1

g/l

38.0

0.01

167

1245

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

173

1290

1.35

3.54

2.7

2.2

g/l

0.0

0.50

162

1198

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

171

1274

1.35

3.52

2.7

2.2

g/l

0.0

0.00

160

1196

(3004451) EKG impression Narrative

242

1.82

3.51

1.4

1.3

—

(3023419) Bacteria identified in Sputum by Culture

646

1.49

3.49

3.3

2.8

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

3.17

3.49

1.4

3.4

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

494

1.56

3.48

1.2

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

179

1.96

3.47

1.3

1.5

—

(3022313) Gas panel - Capillary blood

306

2468

1.25

3.46

5.5

3.7

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

495

1.56

3.46

1.2

1.1

—

(3018405) Lactate [Moles/volume] in Arterial blood

238

1864

1.29

3.44

3.3

4.1

mmol/l

1.4

0.15

228

1837

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

282

1.74

3.38

1.2

1.1

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

184

1397

1.32

3.35

2.7

2.1

g/l

0.0

0.05

173

1302

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

499

1.55

3.35

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

499

1.55

3.35

1.2

1.1

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

408

3407

1.21

3.33

9.6

9.9

1.3

1.4

3.61

402

3385

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

500

1.55

3.32

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

494

1.54

3.27

1.3

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

242

1.78

3.21

1.1

—

(3042631) Mycobacterium sp identified in Specimen

660

1.46

3.17

3.4

2.6

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

269

2162

1.25

3.17

1.5

—

(3015183) Erythrocyte sedimentation rate

404

1.59

3.14

1.1

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

334

0.39

3.13

1.0

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

216

1.81

3.08

5.3

4.0

—

(44790048)

690

1.44

3.06

1.6

1.5

—

(44806118)

690

1.44

3.06

1.6

1.5

—

(44790049)

690

1.44

3.06

1.6

1.5

—

(44790047)

690

1.44

3.06

1.6

1.5

—

(3003740) Influenza virus B Ag [Presence] in Specimen

180

1383

1.31

3.05

1.0

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

584

1.48

3.04

1.7

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

297

2433

1.23

2.97

4.0

3.1

0.7

1.23

285

2334

(3002523) Influenza virus A Ag [Presence] in Specimen

179

1382

1.30

2.94

1.0

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

295

1.67

2.92

1.3

1.2

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

107

765

1.40

2.90

6.4

7.0

mg/l

11.7

11.2

0.50

101

712

(3003181) Sodium [Moles/volume] in Urine

116

842

1.38

2.88

1.7

1.4

mmol/l

64.5

64.8

0.03

668

(4306422)

146

1099

1.33

2.88

1.2

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

141

1056

1.34

2.87

1.1

124.8

115.0

3.43

131

971

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

223

2779

0.80

2.85

1.6

1.7

mg/l

3.2

3.7

0.60

159

1917

(3017315) Amylase [Enzymatic activity/volume] in Urine

328

1.62

2.85

1.5

1.3

u/l

228.7

333.3

1.12

303

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

2.34

2.81

1.2

1.1

pmol/l

6.6

5.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

432

1.53

2.81

1.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

216

1.76

2.79

1.8

2.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

216

1.76

2.79

1.8

2.1

—

(3043409) Potassium [Moles/volume] in Arterial blood

202

1597

1.27

2.78

3.4

4.4

mmol/l

3.8

3.9

1.26

189

1495

(3034891) Synovial lining cells/100 cells in Synovial fluid

270

1.67

2.74

1.7

1.5

4.2

3.5

0.13

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

218

1.75

2.71

1.8

2.1

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

263

2151

1.23

2.70

5.4

3.8

mmol/l

24.5

24.7

0.57

245

2008

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

501

1.48

2.70

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

342

1.58

2.66

2.1

1.5

—

(3045414) Leukocytes [Presence] in Urine

310

2586

1.21

2.63

1.9

1.8

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

328

1.59

2.61

1.3

1.7

nmol/l

1.3

1.2

0.04

257

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

306

1.61

2.57

2.2

1.5

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.19

2.56

1.5

1.7

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.19

2.56

2.0

1.6

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1661

15498

1.09

2.55

1.7

1.6

mmol/l

1.4

1.01

1414

13304

(3012516) Albumin [Mass/volume] in Urine

1661

15498

1.09

2.55

3.5

3.3

mg/l

467.5

402.2

0.21

1136

10112

(3021691) Plasmodium malariae Ab [Titer] in Serum

7.15

2.55

2.4

2.7

—

(3022621) pH of Urine by Test strip

424

3648

1.17

2.54

3.0

2.7

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

709

1.39

2.53

1.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

254

1.66

2.51

1.6

2.1

—

(3006270) Folate [Moles/volume] in Blood

469

1.48

2.49

1.2

1.1

nmol/l

377.0

385.0

0.12

425

(3028679) Herpes simplex virus Ab [Presence] in Serum

413

1.51

2.47

1.1

1.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

271

1.63

2.45

6.6

6.7

mg/l

4701.8

801.5

0.39

193

(3020891) Body temperature

259

2145

1.21

2.39

4.6

4.9

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

615

1.40

2.39

2.6

2.1

mg/l

21.5

22.5

0.06

169

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

250

1.64

2.39

1.1

—

(4198724)

478

0.56

2.37

1.5

3.2

—

(3017704) Immunofixation for Urine

259

1.63

2.34

1.9

1.6

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.15

2.34

1.9

1.5

—

(21494890) Protein electrophoresis panel - 24 hour Urine

477

1.45

2.31

2.0

—

(1175426) CD3 cells/100 lymphocytes in Blood

537

1.42

2.28

1.7

2.1

73.6

73.2

0.09

514

(3020682) Albumin/Creatinine [Ratio] in Urine

1728

16229

1.08

2.26

4.4

4.1

mg/mmol

7.5

10.0

1.71

1171

10694

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

106

1.98

2.25

1.8

1.6

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

497

1.43

2.24

1.7

2.2

—

(3036603) Volume of Urine

367

1.50

2.21

1.8

1.5

1859.0

2094.7

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

303

1.55

2.21

2.2

1.5

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

131

1014

1.30

2.20

1.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1016

11040

0.91

2.18

2.8

2.7

ug/l

0.7

0.24

650

6673

(3044927) Protein electrophoresis panel - Urine

434

1.46

2.17

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

526

1.41

2.16

1.7

2.1

9.9

14.2

1.96

264

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

353

1.50

2.16

1.2

1.1

u/ml

9.6

17.9

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

196

1.69

2.14

1.7

2.0

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

159

1.76

2.13

1.0

1.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

483

4259

1.14

2.12

2.5

2.3

ug/l

6.6

8.0

0.94

435

3805

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

445

1.44

2.11

1.1

ratio

1.0

1.10

158

(3000764) Benzodiazepines [Presence] in Urine

361

4167

0.86

2.11

1.4

2.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

224

1859

1.21

2.07

1.2

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

5.00

2.07

1.0

u/field

1.4

1.5

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

651

1.36

2.04

1.9

1.6

51.2

56.9

0.64

408

(3049717) Cytology report of Urine Cyto stain

218

1809

1.21

2.03

2.3

2.6

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

508

1.40

2.02

1.8

1.5

31.7

31.5

0.01

317

(3009466) Valproate [Moles/volume] in Serum or Plasma

1025

0.73

2.01

4.3

5.4

umol/l

320.5

368.4

2.06

897

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.63

2.00

1.6

1.7

—

(3000093) Morphology [Interpretation] in Blood Narrative

502

1.40

1.97

1.2

1.1

—

(3010937) Rubella virus Ab [Presence] in Serum

2.36

1.94

1.0

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

139

1109

1.26

1.89

1.1

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

2.16

1.87

2.1

2.0

umol/l

1.2

1.3

0.31

(21494755) Public health laboratory ask at order entry panel

816

8891

0.91

1.87

1.3

—

(3028300) Cannabinoids [Presence] in Urine

368

4199

0.87

1.87

1.4

2.3

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

308

1.50

1.87

2.4

1.4

u/ml

19.6

18.9

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

5908

60033

0.93

1.85

3.7

3.6

mmol/l

1.3

0.03

5542

56271

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

450

1.40

1.84

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

190

1.63

1.83

1.1

—

(3027008) Opiates [Presence] in Urine

368

4192

0.87

1.83

1.4

2.2

—

(3016879) Cocaine [Presence] in Urine

339

3883

0.87

1.83

1.4

2.3

—

(3027944) Amphetamines [Presence] in Urine

362

4127

0.87

1.82

1.4

2.2

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.27

1.80

1.0

1.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

271

1.52

1.78

1.4

1.3

titre

70.0

76.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

351

0.57

1.78

4.1

3.2

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

350

0.57

1.76

8.1

6.3

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

379

1.43

1.75

1.2

—

(3047189) Immunofixation for 24 hour Urine

225

1.56

1.72

1.7

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

178

1.63

1.72

1.1

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.92

1.72

1.0

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

123

1534

0.80

1.72

1.1

u/ml

7.3

6.5

0.19

826

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

3.85

1.71

1.0

—

(3006653) Thiamine [Moles/volume] in Blood

315

1.46

1.70

1.1

1.4

nmol/l

142.0

136.4

0.38

315

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

387

3421

1.14

1.70

2.2

2.4

u/l

5389.1

6149.6

0.18

138

1348

(43055514) Macroprolactin [Presence] in Serum or Plasma

215

0.46

1.68

1.3

1.4

—

(3048879) Bone marrow aspiration report

126

1.75

1.67

1.5

2.1

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

450

4022

1.13

1.66

3.1

2.9

ng/l

204.8

168.5

0.76

402

3589

(1001926) Buprenorphine [Presence] in Urine by Screen method

281

3237

0.86

1.66

1.4

2.4

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

180

1.61

1.66

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

2.58

1.65

2.5

2.8

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

133

1075

1.24

1.65

1.4

1.6

—

(3000012) Reticulocyte production index

268

1.50

1.65

1.4

1.5

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.10

1.65

1.1

1.5

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

2.80

1.65

1.0

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

410

1.39

1.63

2.4

2.3

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

324

2839

1.15

1.63

11.2

10.4

mmol/l

23.8

24.2

1.93

305

2670

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

105

1.81

1.62

1.3

1.1

ng/l

40.7

57.5

—

(4034850)

230

1965

1.18

1.62

9.8

8.6

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

139

1697

0.82

1.61

1.1

u/ml

1.2

1.7

0.36

717

(40768806) Pleura Pathology biopsy report

475

0.65

1.61

1.4

1.6

—

(3016750) Collection duration of Urine

336

1.43

1.60

2.6

2.2

min

512.7

494.5

0.66

261

(3022475) Manganese [Moles/volume] in Blood

2.33

1.60

1.3

1.4

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.33

1.60

1.0

1.5

umol/24h

286.4

329.9

—

(3035933) Granulocytes/100 leukocytes in Blood

222

1.53

1.59

1.6

1.5

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

126

1018

1.24

1.58

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1432

15134

0.93

1.57

3.9

3.7

21.4

21.7

0.33

655

6452

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

388

1.39

1.57

1.4

1.5

u/l

5.6

6.6

0.81

337

(3045424) Erythrocytes [Presence] in Urine

121

976

1.24

1.55

1.5

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

184

1.58

1.53

1.1

—

(3025130) Human papilloma virus identified in Specimen

115

925

1.25

1.52

1.9

1.8

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

173

1452

1.20

1.51

1.4

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

537

1.33

1.51

1.4

1.3

nmol/l

1.5

1.4

0.08

478

(3009508) Creatinine [Moles/volume] in Urine

1876

17920

1.06

1.49

3.3

mmol/l

8.4

8.2

1.22

1619

15382

(3011897) Casein IgE Ab [Units/volume] in Serum

127

0.39

1.49

1.0

1.1

—

7.8

—

(3021788) Differential panel - Synovial fluid

124

1009

1.23

1.48

1.5

1.6

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

120

1472

0.81

1.48

1.1

u/ml

0.4

1.4

3.95

653

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.00

1.48

1.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

166

0.48

1.46

1.3

1.2

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.31

1.42

1.7

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

164

1.59

1.42

1.2

1.3

nmol/l

160.4

125.3

0.36

125

(3037121) Protein [Mass/volume] in Urine

225

1943

1.16

1.42

3.3

g/l

0.3

0.23

116

905

(3011985) Renin [Units/volume] in Plasma

101

809

1.25

1.40

1.5

mu/l

58.3

62.5

0.12

727

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

157

1.59

1.40

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.85

1.39

1.0

—

(3045788) Cell count panel - Pleural fluid

434

0.67

1.38

1.3

1.5

—

(3039443) Prostate specific Ag panel - Serum or Plasma

116

1415

0.82

1.38

1.5

1.6

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.00

1.38

1.0

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

751

1.25

1.35

1.2

1.3

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1056

9935

1.07

1.34

1.7

1.8

1.4

0.44

922

8904

(3025018) Bordetella pertussis Ab [Titer] in Serum

384

1.36

1.32

1.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

216

1.48

1.32

1.2

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

700

1.26

1.32

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

133

1107

1.20

1.31

1.2

1.1

au/ml

10.3

12.5

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.81

1.31

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

284

1.41

1.29

1.2

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

114

1.67

1.28

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

285

1.41

1.27

1.2

1.6

u/field

1.5

3.5

1.55

210

(3011288) Drugs identified in Urine by Screen method

245

2784

0.88

1.26

1.8

3.4

—

(3004775) Volume in Urine collected for unspecified duration

431

1.32

1.26

2.5

2.3

800.7

637.7

1.29

310

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.74

1.24

1.1

1.3

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

203

2332

0.87

1.23

1.4

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

1.80

1.21

1.1

1.2

83.8

55.2

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

204

2338

0.87

1.20

1.4

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

620

1.26

1.20

1.4

mmol/l

11.3

12.1

0.34

144

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

203

2326

0.87

1.20

1.4

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.31

1.18

1.0

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

278

2475

1.13

1.18

1.8

1.7

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

1.16

0.0

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

205

2339

0.87

1.15

1.4

—

(3006576) Bicarbonate [Moles/volume] in Blood

207

1.45

1.14

5.7

6.5

mmol/l

24.4

24.6

0.08

195

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

425

0.70

1.12

1.8

1.6

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.00

1.12

1.3

1.7

umol/l

36.8

45.0

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

225

1.42

1.11

2.2

2.5

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

414

1.31

1.11

1.0

1.1

iu/ml

11.5

10.3

0.08

116

(3042111) Morphology [Interpretation] in Bone marrow Narrative

102

844

1.21

1.11

1.4

1.7

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

102

844

1.21

1.11

1.2

1.3

nmol/l

0.3

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.96

1.11

2.0

5.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

674

1.23

1.08

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

185

1.46

1.08

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

130

1104

1.18

1.08

1.5

1.6

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

170

1954

0.87

1.07

1.5

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

365

4007

0.91

1.07

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

391

4277

0.91

1.07

1.5

1.6

—

(3050129) First trimester maternal screen panel - Serum or Plasma

262

2927

0.89

1.07

1.5

1.4

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

1.87

1.07

1.5

mg/l

7.2

1.9

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

296

2664

1.12

1.07

1.3

miu/ml

235.8

223.4

0.21

127

1251

(3019977) pH of Arterial blood

287

1.36

1.06

2.3

3.0

7.4

0.45

(1761868) Lipid panel - Serum or Plasma

2450

25245

0.96

1.06

2.6

2.5

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

605

1.24

1.05

1.5

—

(3014051) Protein [Presence] in Urine by Test strip

147

1265

1.17

1.04

2.3

2.1

—

(3005033) Fetal Nuchal fold Thickness US

165

1892

0.87

1.02

1.4

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

177

0.56

1.01

1.9

2.2

umol/l

14.2

15.6

—

177

(3014271) Vancomycin [Susceptibility]

205

1.42

1.00

2.4

2.6

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

309

1.33

0.98

1.7

2.3

umol/l

76.2

159.0

2.40

156

(3028308) Erythrocytes [#/volume] in Pleural fluid

481

0.75

0.97

1.3

1.5

e6/l

13749.4

76224.4

2.57

282

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.95

0.97

1.3

1.1

—

(40768446) Kidney Pathology biopsy report

301

1.33

0.96

1.9

1.7

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

199

0.60

0.96

1.8

1.9

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.96

0.0

1.2

—

1.6

—

(3016038) Potassium [Moles/volume] in Urine

337

1.31

0.95

1.6

1.2

mmol/l

30.7

36.1

1.04

301

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.89

0.94

1.7

1.3

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

125

1.52

0.93

1.1

1.3

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

329

1.31

0.93

1.1

94.2

95.5

0.13

272

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

109

1.56

0.93

1.4

2.4

—

(3000492) Spirometry study

717

6756

1.07

0.93

1.5

1.4

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

997

0.83

0.93

1.3

1.4

mmol/l

6.8

7.0

0.42

728

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

143

0.56

0.93

1.0

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

167

1897

0.88

0.93

1.4

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

124

1435

0.86

0.90

1.1

u/ml

0.7

2.2

4.34

363

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

176

1.42

0.90

1.1

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

151

1.46

0.90

1.2

1.1

76.3

75.6

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

209

1868

1.12

0.89

1.9

pmol/l

205.7

202.7

0.16

201

1777

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

168

1.43

0.89

1.0

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

227

2523

0.90

0.89

1.5

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

6271

63254

0.95

0.88

4.4

4.3

mmol/l

2.8

6.10

5878

59379

(3040151) Glucose [Moles/volume] in Capillary blood

611

1.21

0.87

6.8

17.1

mmol/l

7.1

7.3

0.12

510

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.86

0.87

1.0

1.2

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

131

0.53

0.87

2.4

2.3

—

(3012441) Differential panel - Pleural fluid

471

0.76

0.86

1.3

1.5

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

999

0.84

0.86

1.0

1.1

u/ml

0.3

0.6

0.30

222

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.82

0.85

1.3

1.0

—

(4010399)

438

4070

1.08

0.85

1.4

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

686

1.20

0.85

3.2

3.0

nmol/l

0.8

0.06

518

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

415

1.25

0.84

1.4

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

239

1.34

0.83

1.1

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

371

1.27

0.83

1.2

1.4

ug/l

6.7

7.3

0.19

324

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

488

1.23

0.83

3.9

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

1.69

0.82

1.0

1.1

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

216

1947

1.11

0.82

2.2

2.5

ug/l

276.7

519.9

2.23

196

1822

(3000475) Leukocytes [#/volume] in Synovial fluid

146

1285

1.14

0.82

1.6

e6/l

9035.9

14092.0

1.65

110

925

(21494434) Karyotype in Bone marrow

444

1.24

0.81

1.2

—

(3035637) Corticotropin [Mass/volume] in Plasma

810

1.17

0.81

1.8

1.6

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.70

0.80

1.0

1.2

u/l

40.0

11.7

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

329

1.28

0.80

1.5

1.6

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

186

1666

1.12

0.79

1.2

1.4

mg/l

499.4

501.6

0.02

181

1582

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

164

1459

1.13

0.78

1.2

1.3

mmol/l

3.8

3.7

0.25

150

1373

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.67

0.78

1.0

1.2

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

131

1.45

0.78

2.9

4.0

u/l

93.0

97.5

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.56

0.78

1.9

1.8

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.59

0.78

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

140

1.43

0.76

1.0

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.77

0.76

1.3

1.4

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

120

1049

1.15

0.76

1.1

1.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

142

1256

1.13

0.75

1.9

2.4

nmol/l

0.9

0.60

123

1061

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

6166

62161

0.96

0.75

4.0

3.9

mmol/l

1.4

1.58

5811

58490

(40768800) Prostate Pathology biopsy report

1047

0.86

0.74

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1056

10141

1.05

0.73

2.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

111

970

1.15

0.71

1.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

765

1.17

0.71

1.4

pmol/l

339.6

299.4

0.51

586

(4024509)

489

1.21

0.71

1.7

1.5

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

264

0.72

0.71

1.9

2.1

ug/min

11.2

214.7

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

490

1.21

0.70

1.4

2.0

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

446

4748

0.94

0.70

1.2

iu/ml

88.7

154.8

5.55

166

1795

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

169

1.36

0.69

2.3

3.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

169

1.36

0.69

2.3

3.1

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

230

1.31

0.69

1.2

116.4

105.8

0.82

211

(3014133) Dog dander IgE Ab [Units/volume] in Serum

106

1209

0.88

0.68

1.1

u/ml

2.6

3.8

0.77

485

(3017446) Testosterone [Moles/volume] in Serum or Plasma

624

5925

1.06

0.68

2.2

nmol/l

13.3

13.1

0.22

569

5330

(3003434) Protein [Mass/volume] in Pleural fluid

596

0.82

0.68

1.3

1.5

g/l

33.5

33.7

0.04

541

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

222

1.31

0.67

1.2

103.8

88.9

1.31

106

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

153

1.37

0.66

1.2

76.8

68.2

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.79

0.66

1.6

1.9

—

0.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.59

0.65

1.0

1.1

—

(3030313) Adrenal Ab [Titer] in Serum

1.57

0.65

1.1

1.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.57

0.65

1.2

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

1117

0.88

0.64

1.1

u/ml

7.3

4.6

0.47

460

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

233

1.29

0.64

1.2

1.1

101.3

90.4

2.52

111

(3023199) Leukocytes [#/volume] in Pleural fluid

547

0.82

0.63

1.3

1.5

e6/l

2452.9

2643.6

0.12

395

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

269

1.27

0.63

1.6

1.8

—

(3045142) Bone marrow Pathology biopsy report

579

1.18

0.63

1.1

1.4

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

1.50

0.63

14.2

7.1

58.8

71.0

—

(3037556) Urate [Mass/volume] in Serum or Plasma

155

1.36

0.62

1.0

1.3

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

460

1.20

0.62

2.5

3.0

—

24.0

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

360

1.22

0.62

4.9

7.0

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

406

1.21

0.61

2.0

2.7

35.6

41.4

0.58

137

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

501

0.82

0.61

1.8

2.7

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.67

0.61

1.4

1.1

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

152

0.66

0.61

1.0

1.1

u/ml

0.1

5.5

—

112

(4281824)

533

0.82

0.61

1.1

1.2

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.60

0.0

1.0

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

396

3729

1.07

0.59

1.3

1.4

iu/l

28.2

25.2

0.95

343

3184

(3010144) Erythrocytes [#/volume] in Synovial fluid

482

1.18

0.59

1.3

1.4

e6/l

265632.5

72917.8

0.62

341

(40768795) Lymph node Pathology biopsy report

538

1.17

0.58

1.2

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

208

0.72

0.58

1.9

2.8

umol/l

29.2

28.7

—

148

(3034426) Prothrombin time (PT)

264

1.25

0.57

1.4

1.3

—

(4015189)

123

1.38

0.57

1.8

2.3

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

1.48

0.57

2.3

pmol/l

53.3

69.0

0.52

(4211845)

283

1.24

0.56

2.2

2.8

—

(3002619) Bacteria identified in Specimen by Culture

115

1.39

0.56

1.5

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

589

6167

0.95

0.56

2.0

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.45

0.56

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

142

1.34

0.54

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

142

1.34

0.54

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

142

1.34

0.54

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

142

1.34

0.54

1.2

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.50

0.54

1.0

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

376

1.20

0.54

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.48

0.53

1.6

1.3

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

525

1.16

0.53

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

134

1.34

0.53

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.43

0.52

1.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

241

1.25

0.52

1.0

1.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

251

1.24

0.50

1.5

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

251

1.24

0.50

1.5

1.4

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.41

0.50

1.0

1.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

473

4510

1.05

0.49

2.3

au/ml

25.8

21.2

0.30

304

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

307

1.21

0.49

2.1

2.4

ug/l

25.4

185.5

0.95

284

(40757373) Influenza virus identified in Isolate

110

1.36

0.48

1.3

1.6

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.40

0.48

1.0

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

363

1.19

0.48

1.1

—

(3003129) Base excess in Capillary blood by calculation

119

1.35

0.48

2.0

1.7

mmol/l

-0.5

0.7

0.33

111

(3020650) Glucose [Presence] in Urine

190

1.26

0.47

1.3

1.4

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.49

0.47

1.0

1.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

522

1.15

0.47

2.1

2.6

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

137

1.31

0.47

1.0

1.2

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

0.60

0.45

1.2

3.6

umol/l

18.1

43.8

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

384

1.17

0.45

1.5

1.9

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

138

1.31

0.45

12.6

5.1

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.40

0.45

1.3

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

281

2650

1.06

0.45

2.4

2.3

—

(3041806) Other cells [#/volume] in Blood by Manual count

366

1.18

0.44

1.6

1.5

—

(3019832) Treponema pallidum Ab [Presence] in Serum

881

9085

0.97

0.44

1.7

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

386

1.17

0.43

1.1

nmol/l

0.7

6.1

—

(40765096) Chromosome analysis panel by Banding

157

1.27

0.43

1.2

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.61

0.43

1.0

1.4

—

(3023511) Choriogonadotropin [Units/volume] in Urine

184

1714

1.08

0.42

1.5

1.3

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

113

1237

0.91

0.42

1.4

1.5

nmol/l

0.4

0.04

994

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

0.64

0.42

1.0

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

0.63

0.42

1.2

1.1

—

(3024928) Oxygen saturation in Venous blood

132

1215

1.09

0.41

4.5

3.5

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.52

0.41

1.2

1.0

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

0.00

0.41

0.0

1.2

—

1.1

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

0.41

0.0

1.1

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

7.0

—

0.2

—

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

0.00

0.40

0.0

1.4

—

25.9

—

(3044290) Cell count panel - Cerebral spinal fluid

148

1371

1.08

0.40

1.3

1.4

—

(3022689) Creatine [Moles/volume] in Urine

183

0.76

0.40

2.9

1.5

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

150

1.27

0.40

1.0

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

150

1.27

0.40

1.0

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

150

1.27

0.40

1.0

1.1

—

(37019676) Renin [Units/volume] in Plasma --supine

0.00

0.40

0.0

1.3

—

18.7

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

106

1159

0.91

0.40

1.2

1.3

ug/l

2.4

4.0

3.33

1062

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

177

1654

1.07

0.39

1.5

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.39

0.0

1.4

—

3.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1146

11187

1.03

0.39

2.2

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.39

0.38

1.0

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

486

1.13

0.37

1.3

u/ml

0.6

1.0

0.41

196

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.35

0.37

1.0

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

111

1205

0.92

0.36

1.3

1.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

106

1153

0.92

0.36

1.3

u/l

25.1

22.9

0.31

959

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

688

6675

1.03

0.35

7.5

6.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

126

0.71

0.35

1.9

1.5

—

(3016330) Potassium [Moles/time] in 24 hour Urine

1.34

0.34

1.3

1.4

—

97.6

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.32

0.33

3.1

1.7

ng/l

136.3

137.7

0.01

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1873

19025

0.98

0.33

4.3

4.2

ug/l

2.1

2.6

1.56

1690

17269

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

605

1.11

0.33

1.0

1.1

mg/l

224.7

257.6

1.56

534

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

265

1.17

0.33

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

219

1.19

0.33

1.6

2.2

e6/l

275.3

164.5

0.59

116

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.67

0.33

1.3

1.2

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

137

1.24

0.32

1.2

pmol/l

238.7

284.3

0.31

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

252

0.83

0.32

1.1

—

(1002224) Polysomnography panel

318

3316

0.96

0.32

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

144

1350

1.07

0.31

1.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

370

1.14

0.31

1.2

1.3

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

229

0.83

0.30

1.0

1.1

u/ml

0.3

2.6

—

130

(3016244) Insulin [Units/volume] in Serum or Plasma

473

0.89

0.30

2.6

3.5

mu/l

40.1

30.2

0.54

447

(3051593) INR in Capillary blood by Coagulation assay

194

1.19

0.29

4.1

10.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

281

2694

1.04

0.29

1.7

1.8

nmol/l

37.9

38.9

0.29

276

2624

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

148

1.22

0.29

1.1

—

(3017509) Phencyclidine [Presence] in Urine

108

0.74

0.29

1.1

1.7

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

111

0.72

0.28

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

418

0.88

0.28

1.4

1.3

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

596

0.91

0.28

1.5

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

156

1475

1.06

0.28

1.3

1.5

e6/l

757.6

3450.1

0.55

130

1200

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

156

1475

1.06

0.28

1.2

1.4

e6/l

91.7

21.7

0.46

121

1134

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

429

4155

1.03

0.27

1.3

au/ml

58.9

47.0

0.41

169

(3044007) Cell count panel - Peritoneal fluid

161

0.81

0.27

1.8

2.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

5936

59603

0.98

0.27

4.0

mmol/l

5.8

0.02

5503

55334

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

624

1.09

0.27

1.1

1.2

mg/l

42.6

40.3

0.15

521

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

634

1.09

0.26

1.2

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

510

0.90

0.26

1.0

1.1

u/ml

0.8

3.0

1.06

124

(3021387) Prolactin [Units/volume] in Serum or Plasma

302

3134

0.96

0.26

1.5

1.6

mu/l

286.3

295.5

0.22

273

2837

(4146454)

529

1.10

0.26

2.4

2.7

—

(3006462) Nitrate [Presence] in Urine

254

1.14

0.25

2.3

2.8

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.20

0.25

1.2

1.1

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

105

1.24

0.24

2.8

2.9

u/l

754.8

1782.6

0.61

(3008536) Aspergillus sp Ab [Presence] in Serum

124

1.21

0.23

1.9

2.4

—

(1617658) Protocol used for examination of sentinel lymph nodes

370

0.89

0.23

1.1

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

671

0.92

0.23

1.5

1.6

mmol/l

7.2

7.6

0.65

412

(40757494) Bilirubin.total [Moles/volume] in Blood

304

1.12

0.22

2.4

umol/l

12.2

20.8

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

247

1.13

0.22

1.1

1.2

g/l

0.3

0.48

195

(3016018) Differential panel - Cerebral spinal fluid

728

1.07

0.22

1.2

1.4

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.27

0.22

3.4

2.9

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

628

0.92

0.22

1.6

1.5

promille

1.1

1.4

0.89

471

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

257

1.13

0.22

1.2

1.1

ng/l

149.9

355.3

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

113

1070

1.06

0.21

1.5

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.21

0.0

1.0

—

(36303858) Crystals [Presence] in Urine

0.00

0.21

0.0

1.1

—

(3025296) Carrot IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

6.1

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.16

0.21

1.4

2.1

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

11541.6

—

(3020934) Sesame Seed IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.5

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

1.24

0.20

1.0

1.2

u/ml

0.0

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

201

1934

1.04

0.20

1.9

1.8

—

(3036670) Protein [Mass/volume] in Synovial fluid

136

1.18

0.20

1.4

1.2

g/l

37.7

38.5

0.09

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

221

1.13

0.20

2.3

2.2

—

(4027681)

490

1.08

0.19

1.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

127

1.18

0.19

1.0

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

127

1.18

0.19

1.1

1.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

165

1.15

0.19

2.2

1.7

—

(3009015) Lactate [Moles/volume] in Synovial fluid

1.15

0.19

1.0

1.3

mmol/l

7.9

5.6

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

219

2117

1.04

0.18

1.6

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

5573

55920

0.99

0.18

5.3

5.0

mmol/mol

38.9

39.0

0.26

5248

52619

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

140

1342

1.04

0.18

2.7

2.4

ug/min

87.4

127.7

0.64

874

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

1.17

0.17

1.0

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.15

0.17

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.13

0.17

1.0

1.1

—

(3001556) Androgen free Index in Serum or Plasma

110

1.18

0.17

1.2

1.3

—

(3044009) aPTT.lupus sensitive (LA screen)

1.11

0.17

1.0

1.2

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

382

0.92

0.17

1.3

1.4

mmol/l

5.3

5.6

1.22

362

(4133840)

215

0.88

0.16

1.4

1.1

—

(3042517) Benzodiazepines panel - Urine

120

0.83

0.16

2.3

—

(3020491) Glucose [Moles/volume] in Blood

467

1.07

0.15

1.6

1.8

mmol/l

7.0

6.3

0.84

340

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

6237

62515

0.99

0.15

4.2

4.0

mmol/l

4.7

4.76

5906

59048

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.13

0.15

1.3

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

226

1.11

0.15

1.0

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

323

1.08

0.14

1.0

ng/l

304.4

318.6

0.18

232

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

707

0.95

0.14

1.1

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

113

1176

0.96

0.14

2.2

titre

14.8

8.4

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

233

2269

1.03

0.14

1.7

1.8

—

(3023410) Appearance of Cerebral spinal fluid

686

0.95

0.14

1.3

1.7

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

116

1116

1.04

0.14

1.1

iu/ml

27.2

9808.3

0.64

275

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

480

4883

0.98

0.14

1.8

1.9

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

765

7550

1.01

0.14

1.8

—

(40758292) HTLV I+II Ab panel - Serum

122

1.15

0.13

1.3

1.4

—

(4094501)

165

1601

1.03

0.13

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

510

0.94

0.13

1.1

1.6

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

393

1.07

0.13

2.2

1.9

u/field

1.5

1.7

0.30

175

(3024263) Appearance of Synovial fluid

296

1.08

0.13

1.3

1.8

—

(3044941) Cell count panel - Synovial fluid

874

1.04

0.12

1.5

1.4

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

179

0.89

0.12

1.7

2.0

e6/l

9933.7

13457.1

0.12

105

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

269

2745

0.98

0.11

2.2

3.1

u/ml

45.1

45.3

0.00

262

2647

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

143

1.12

0.11

1.3

1.6

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

147

0.88

0.11

1.0

1.1

—

1.7

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

582

1.05

0.11

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

153

1.11

0.11

6.5

6.9

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

352

0.94

0.10

5.5

7.1

u/ml

32.8

7682.7

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

603

1.05

0.10

3.8

4.7

u/ml

55.1

73.2

0.24

182

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

889

1.04

0.10

1.2

1.3

u/l

33.0

37.1

0.17

776

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.14

0.10

1.0

1.1

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

1.09

0.09

1.0

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

1.09

0.09

1.4

1.2

—

2.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

321

1.06

0.09

1.0

ng/l

752.9

765.5

0.06

224

(40758047) Lysozyme [Mass/volume] in Pleural fluid

1.11

0.09

1.2

mg/l

6.8

10.3

—

(3050794) Legionella sp Ab [Presence] in Serum

1.11

0.09

1.0

1.1

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

1.09

0.08

1.3

1.4

75.6

71.0

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

1.09

0.08

1.0

1.6

pmol/l

5.1

15.5

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.03

0.08

1.0

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

113

0.88

0.08

7.2

7.0

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

440

4451

0.99

0.08

1.5

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.09

0.08

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

234

1.07

0.08

3.8

2.9

—

(21491868) Cryoglobulin [Mass/volume] in Serum

234

1.07

0.08

1.2

g/l

—

0.2

—

(3019174) dRVVT (LA screen)

1.08

0.08

1.0

1.2

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.08

0.08

1.6

1.9

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

1.04

0.08

1.3

u/l

25.7

495.7

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

323

1.05

0.07

1.0

ng/l

36.7

44.8

0.95

226

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

631

0.97

0.07

1.9

2.2

nmol/l

21.4

20.0

0.53

600

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.07

0.07

1.0

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.12

0.06

1.0

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

103

1054

0.98

0.06

1.2

—

(3033799) Differential panel - Peritoneal fluid

173

0.92

0.06

2.1

2.0

—

(44806071)

104

0.87

0.06

1.1

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

782

1.02

0.05

1.1

—

17.7

—

(3008295) Osmolality of Serum or Plasma

576

0.97

0.05

1.3

1.5

mosm/kgh2o

280.3

281.4

0.10

447

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

307

1.04

0.05

1.7

1.6

nmol/l

4.5

12.8

0.50

245

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

104

1021

1.02

0.05

1.2

1.6

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

734

1.02

0.04

1.3

1.4

pmol/l

93.0

111.6

0.16

215

(3038071) Oxygen [Partial pressure] in Mixed venous blood

140

0.93

0.04

5.8

7.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

159

1571

1.01

0.04

1.9

2.0

iu/l

3.5

4.4

1.06

591

(44813793)

487

1.03

0.04

1.0

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

503

0.97

0.04

1.2

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

288

2902

0.99

0.03

2.0

1.9

—

(3000034) Microalbumin [Mass/volume] in Urine

528

1.02

0.03

3.6

3.1

mg/l

60.6

60.0

0.01

397

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.09

0.03

1.0

1.1

—

(3045716) Anion gap in Serum or Plasma

241

1.04

0.02

3.6

2.6

mmol/l

9.2

9.4

0.07

179

(3020874) Milk IgE Ab [Units/volume] in Serum

490

1.02

0.02

1.0

1.1

u/ml

5.0

2.6

0.21

139

(40768793) Breast Pathology biopsy report

112

1132

0.99

0.02

1.3

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

232

1.03

0.02

1.1

1.2

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.08

0.02

5.9

7.4

—

(3026470) Cobalt [Mass/volume] in Blood

278

0.97

0.02

2.1

2.0

ug/l

2.1

3.2

1.32

244

(3005011) Chlamydia sp Ab [Titer] in Serum

103

1.07

0.02

1.8

1.5

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

227

2282

0.99

0.01

1.5

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

121

1220

0.99

0.01

3.9

3.2

mg/l

21.9

26.2

0.96

749

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

412

1.02

0.01

1.0

1.1

u/l

1.0

1.1

0.25

182

(3035880) pH of Pleural fluid

247

0.97

0.01

1.3

—

(44806420)

106

0.94

0.01

2.4

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

136

0.96

0.00

1.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

667

6662

1.00

0.00

3.9

4.0

31.9

31.5

0.51

514

4781

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

142

1414

1.00

0.00

1.7

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

177

1.02

0.00

1.0

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

105

0.95

0.00

1.0

—

(3017569) Oxygen content in Arterial blood

225

1.02

0.00

2.4

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

112

0.98

0.00

1.0

1.3

mg/l

0.3

123.7

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

148

1.01

0.00

1.4

2.7

ng/l

106.4

123.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

252

0.99

0.00

2.5

2.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

139

1.01

0.00

1.0

1.3

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

404

4042

1.00

0.00

3.4

pmol/l

4.5

0.00

364

3623

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

231

1.00

0.00

1.0

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

259

2591

1.00

0.00

1.5

1.4

u/l

8.7

0.01

211

2118

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.0

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.0

1.1

—

(40762887) Creatinine [Moles/volume] in Blood

0.00

0.0

1.1

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(4038314)

0.94

0.00

1.0

1.2

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.96

0.00

2.4

2.6

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

0.0

1.0

—

(3014891) Appearance of Pleural fluid

0.92

0.00

2.0

1.6

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

0.94

0.00

1.8

2.1

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(40759632) Porphyrins [Mass/mass] in Stool

0.00

0.0

1.1

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

0.0

1.0

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.96

0.00

1.0

1.1

—

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

0.0

1.0

—

(40760512) CD34 cells/100 cells in Bone marrow

0.00

0.0

1.2

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

0.0

1.0

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

38.6

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

0.99

0.00

11.1

10.9

mmol/l

5.3

6.2

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: K11_UC_STRICT – Ulcerative colitis (strict definition, require KELA)

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Ulcerative colitis (strict definition, require KELA)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Ulcerative colitis (strict definition, require KELA) (K11_UC_STRICT)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints